{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "6d2ce2cf-e139-4045-b6b3-802ddfd248c6",
   "metadata": {},
   "source": [
    "# Predicting Clinical Trial Terminations\n",
    "### Notebook 2: Preprocessing & EDA\n",
    "\n",
    "**Author: Clement Chan**\n",
    "\n",
    "---\n",
    "Notes on the notebook:\n",
    "- The previous notebook consists of the raw dataset and the steps involved in cleaning. We also performed preliminary EDA and highlighted the distribution of important columns and analyzed what potential features we should include in the model.\n",
    "- In this notebook, we will complete a second round of more in-depth cleaning and exploratory data analysis. Our goal is to create a baseline model for statistical analysis, prepare for feature engineering and modelling."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0d81d7bc-34ce-4d8b-b87b-db5f478575c9",
   "metadata": {},
   "source": [
    "### Data Dictionary for this notebook that is based on clinicaltrials.gov:\n",
    "\n",
    "---\n",
    "\n",
    "| Column | Description                                  |Data Type|\n",
    "|-------|--------------------------------------------|-------|\n",
    "| Study Title | Title of the Clinical Trial           | object |\n",
    "| Study Status | Binary column, 0 for Completed Trials and 1 for Terminated Trials | int |\n",
    "| Brief Summary | Short description of the clinical study (Includes study hypothesis) | object |\n",
    "| Study Results | Whether the results are posted (yes = 1 or no = 0) | int|\n",
    "| Conditions | Primary Disease or Condition being studied     | object |\n",
    "| Interventions | The methods used in the trial to reach the outcome                 | object |\n",
    "| Primary Outcome Measures | Description of specific primary outcome | object |\n",
    "| Secondary Outcome Measures | Description of specific secondary outcome | object |\n",
    "| Sponsor | The corporation or agency that initiates the study | object |\n",
    "| Collaborators | Other organizations that provide support | object |\n",
    "| Sex | All: No limit on eligibility based on sex, Male: Only male participants, Female: Only female participants | int |\n",
    "| Age | Age group of participants: ADULT, OLDER_ADULT, CHILD  | int |\n",
    "| Phases | Clinical trial phase of the study | int |\n",
    "| Enrollment | Total number of participants in a study | int |\n",
    "| Funder Type | Funding type in category? | int |\n",
    "| Study Type | Interventional = 1, Observational = 0 | int |\n",
    "| Study Design | Study design based on study type | object |\n",
    "| Start Date | Estimated/Actual date the first participant was enrolled | datetime |\n",
    "| Primary Completion Date | Date the final participant was examined for the first outcome | datetime |\n",
    "| Completion Date | Date the final participant was examined | datetime |\n",
    "| Locations | Where the clinical study will be held | object |"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b0a868a4-251d-4f72-9d69-c3361ca34940",
   "metadata": {},
   "source": [
    "**Importing Libraries**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "1e667164-1ed8-4b86-ba4c-d6c789bb66dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7f2c52a1-790f-4f49-a1ff-c7690b39f400",
   "metadata": {},
   "source": [
    "<a id = 'toc'><a/>\n",
    "## Table of Contents\n",
    "\n",
    "---\n",
    "1. [Data Preprocessing](#prep)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ddd3bf0e-f487-4b29-a055-651ead069a58",
   "metadata": {},
   "source": [
    "**Load the dataset**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "0b9df7e6-a323-49c7-a0d4-413cb951e791",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>...</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Oral Ketone Monoester Supplementation and Rest...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>People who report subjective memory complaints...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cerebrovascular Function|Cognition</td>\n",
       "      <td>other: placebo|dietary_supplement: Î²-ohb</td>\n",
       "      <td>Brain network connectivity, Functional connect...</td>\n",
       "      <td>Working memory, Computer battery to assess wor...</td>\n",
       "      <td>McMaster University</td>\n",
       "      <td>Alzheimer's Society of Brant, Haldimand Norfol...</td>\n",
       "      <td>...</td>\n",
       "      <td>30</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2023-10-25</td>\n",
       "      <td>2024-08</td>\n",
       "      <td>2024-08</td>\n",
       "      <td>2023-08-15</td>\n",
       "      <td>2023-12-01</td>\n",
       "      <td>McMaster University, Hamilton, Ontario, L8S 4K...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>...</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>...</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...    COMPLETED   \n",
       "1  Oral Ketone Monoester Supplementation and Rest...   RECRUITING   \n",
       "2  Investigating the Effect of a Prenatal Family ...    COMPLETED   \n",
       "3  Pre-exposure Prophylaxis (PrEP) for People Who...    WITHDRAWN   \n",
       "4  Tailored Inhibitory Control Training to Revers...    COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...            NO   \n",
       "1  People who report subjective memory complaints...            NO   \n",
       "2  The purpose of this study is to measure the di...            NO   \n",
       "3  People who inject drugs (PWID) experience high...            NO   \n",
       "4  Insufficient inhibitory control is one pathway...            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1                 Cerebrovascular Function|Cognition   \n",
       "2  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "3                             Intravenous Drug Abuse   \n",
       "4  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1           other: placebo|dietary_supplement: Î²-ohb   \n",
       "2  other: family planning counseling let by commu...   \n",
       "3  behavioral: prep uptake/adherence intervention...   \n",
       "4  behavioral: person-centered inhibitory control...   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Brain network connectivity, Functional connect...   \n",
       "2  Self-reported contraceptive use, 6 months post...   \n",
       "3  PrEP uptake by self-report, measured using 1 i...   \n",
       "4  Inhibitory control performance, Task 1, Perfor...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Working memory, Computer battery to assess wor...   \n",
       "2  Intent to use contraception in the future, 6 m...   \n",
       "3  Participant satisfaction with intervention con...   \n",
       "4  Far transfer to a task related to inhibitory c...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1                         McMaster University   \n",
       "2  Planned Parenthood League of Massachusetts   \n",
       "3                           Boston University   \n",
       "4                        University of Oregon   \n",
       "\n",
       "                                       Collaborators  ... Enrollment  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...  ...        250   \n",
       "1  Alzheimer's Society of Brant, Haldimand Norfol...  ...         30   \n",
       "2          Society for Family Planning Research Fund  ...        176   \n",
       "3            National Institute on Drug Abuse (NIDA)  ...          0   \n",
       "4                                               none  ...        103   \n",
       "\n",
       "  Funder Type      Study Type  \\\n",
       "0       OTHER  INTERVENTIONAL   \n",
       "1       OTHER  INTERVENTIONAL   \n",
       "2       OTHER  INTERVENTIONAL   \n",
       "3       OTHER  INTERVENTIONAL   \n",
       "4       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...  2018-08-20   \n",
       "1  Allocation: RANDOMIZED|Intervention Model: CRO...  2023-10-25   \n",
       "2  Allocation: NON_RANDOMIZED|Intervention Model:...     2013-08   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...     2021-03   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...     2014-09   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Last Update Posted  \\\n",
       "0              2019-01-20      2019-02-28   2018-08-14         2019-05-21   \n",
       "1                 2024-08         2024-08   2023-08-15         2023-12-01   \n",
       "2                 2014-12         2014-12   2013-05-15         2015-08-17   \n",
       "3                 2022-03         2022-03   2019-03-11         2021-03-10   \n",
       "4                 2016-04         2016-05   2016-10-26         2016-10-26   \n",
       "\n",
       "                                           Locations  \n",
       "0           Sangath, New Delhi, Delhi, 110016, India  \n",
       "1  McMaster University, Hamilton, Ontario, L8S 4K...  \n",
       "2  Palestinian Ministry of Health Maternal Child ...  \n",
       "3                                            unknown  \n",
       "4  University of Oregon, Social and Affective Neu...  \n",
       "\n",
       "[5 rows x 23 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# make sure to not include the index_col\n",
    "df = pd.read_csv('updated_ctg.csv', index_col = 0)\n",
    "\n",
    "# First 5 rows of dataset\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9b896ad3-9252-4ec5-a8bc-602db9eb6c0b",
   "metadata": {},
   "source": [
    "Let's find the total number of rows and columns in the data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "0fd25472-a13e-4665-a7f2-5405e9b02169",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The dataset has 482350 rows and 23 columns.\n"
     ]
    }
   ],
   "source": [
    "print(f'The dataset has {df.shape[0]} rows and {df.shape[1]} columns.')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d508b7ad-f18f-4d52-b2fc-8355cd647024",
   "metadata": {},
   "source": [
    "Check the information of the dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8da5d301-ffba-4b80-9189-f8b51a938d21",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 482350 entries, 0 to 482349\n",
      "Data columns (total 23 columns):\n",
      " #   Column                      Non-Null Count   Dtype \n",
      "---  ------                      --------------   ----- \n",
      " 0   Study Title                 482350 non-null  object\n",
      " 1   Study Status                482350 non-null  object\n",
      " 2   Brief Summary               482350 non-null  object\n",
      " 3   Study Results               482350 non-null  object\n",
      " 4   Conditions                  482350 non-null  object\n",
      " 5   Interventions               482350 non-null  object\n",
      " 6   Primary Outcome Measures    482350 non-null  object\n",
      " 7   Secondary Outcome Measures  482350 non-null  object\n",
      " 8   Sponsor                     482350 non-null  object\n",
      " 9   Collaborators               482350 non-null  object\n",
      " 10  Sex                         482350 non-null  object\n",
      " 11  Age                         482350 non-null  object\n",
      " 12  Phases                      482350 non-null  object\n",
      " 13  Enrollment                  482350 non-null  int64 \n",
      " 14  Funder Type                 482350 non-null  object\n",
      " 15  Study Type                  482350 non-null  object\n",
      " 16  Study Design                482350 non-null  object\n",
      " 17  Start Date                  482350 non-null  object\n",
      " 18  Primary Completion Date     482350 non-null  object\n",
      " 19  Completion Date             482350 non-null  object\n",
      " 20  First Posted                482350 non-null  object\n",
      " 21  Last Update Posted          482350 non-null  object\n",
      " 22  Locations                   482350 non-null  object\n",
      "dtypes: int64(1), object(22)\n",
      "memory usage: 88.3+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bba39713-6f74-4778-8ceb-c53f3a70662e",
   "metadata": {},
   "source": [
    "In the previous notebook, our approach was to drop columns that contain a large amount of missing values, and impute them with the string 'unknown', 'missing', and 'none'. Now, we will target specific columns that seem to have a big impact or significance in determining the `Study Status` variable.\n",
    "\n",
    "Since the `Study Status` column is our main dependent variable that we are predicting. Let's explore the distribution again, and see if we can minimize the amount of unique values or categories.\n",
    "- Start by looking at the value counts\n",
    "- Visualize the distribution of the categories\n",
    "- Group common categories or remove categories that are insignificant to the model."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "8cf48322-3535-43ef-a1ee-515f6151404a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                    263380\n",
       "RECRUITING                    66150\n",
       "UNKNOWN                       64828\n",
       "TERMINATED                    28014\n",
       "NOT_YET_RECRUITING            20055\n",
       "ACTIVE_NOT_RECRUITING         19702\n",
       "WITHDRAWN                     13716\n",
       "ENROLLING_BY_INVITATION        3931\n",
       "SUSPENDED                      1646\n",
       "NO_LONGER_AVAILABLE             446\n",
       "AVAILABLE                       259\n",
       "APPROVED_FOR_MARKETING          197\n",
       "TEMPORARILY_NOT_AVAILABLE        26\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "c089256a-7934-4a9a-ae1a-b8c4a15befc9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Visualize counts with a graph\n",
    "plt.figure()\n",
    "\n",
    "df['Study Status'].value_counts().plot(kind='barh')\n",
    "\n",
    "plt.title('Number of Studies in Each study status'.title())\n",
    "plt.ylabel('Study Status')\n",
    "plt.xlabel('Number of Studies')\n",
    "\n",
    "sns.despine()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff44ac73-1c66-4f59-971a-b4a13e79e00f",
   "metadata": {},
   "source": [
    "Most of the studies have been completed, which can cause some data imbalance in other classes such as our targeted 'Terminated' category. Let's continue with the cleaning, and see where we can group common categories together starting with the lowest counts `TEMPORARILY_NOT_AVAILABLE`."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "0295de14-bbe5-4e21-9e6d-dc5ffc3a42e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "# this option displays all columns in the dataframe\n",
    "pd.options.display.max_columns = None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "9e637507-a8c0-4d31-a590-8a173f240565",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>11239</th>\n",
       "      <td>Thrombosomes for Expanded Access Use</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>Expanded use of Thrombosomes where a clinical ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Bleeding</td>\n",
       "      <td>biological: thrombosomesÂ®</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Cellphire Therapeutics, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-11-06</td>\n",
       "      <td>2022-01-28</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47190</th>\n",
       "      <td>A Phase I Clinical Study of the Safety, Tolera...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>This study is designed to multiple dose and do...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>drug: hx-1171</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Biotoxtech Co., Ltd</td>\n",
       "      <td>none</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-06-28</td>\n",
       "      <td>2013-06-28</td>\n",
       "      <td>Asan Medical Center, Special City of Seoul, Ko...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53091</th>\n",
       "      <td>Treating Amyotrophic Lateral Sclerosis (ALS) W...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>R(+) pramipexole dihydrochloride monohydrate \\...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Amyotrophic Lateral Sclerosis</td>\n",
       "      <td>drug: r(+) pramipexole dihydrochloride monohyd...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Bennett, James P., Jr., M.D., Ph.D.</td>\n",
       "      <td>University of Pittsburgh|University of Nebraska</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2008-01-16</td>\n",
       "      <td>2012-07-25</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53366</th>\n",
       "      <td>Development of a Fall Prevention and Fall Dete...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>The investigators plan to conduct a first-stag...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Parkinson's Disease</td>\n",
       "      <td>other: portable motion detector</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Far Eastern Memorial Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2010-12-20</td>\n",
       "      <td>2010-12-20</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104237</th>\n",
       "      <td>Post-trial Access for Nipocalimab in Participa...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>The purpose of this post-trial access (PTA) pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Warm Autoimmune Hemolytic Anemia</td>\n",
       "      <td>drug: nipocalimab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>unknown</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2022-02-03</td>\n",
       "      <td>2024-01-23</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "11239                Thrombosomes for Expanded Access Use   \n",
       "47190   A Phase I Clinical Study of the Safety, Tolera...   \n",
       "53091   Treating Amyotrophic Lateral Sclerosis (ALS) W...   \n",
       "53366   Development of a Fall Prevention and Fall Dete...   \n",
       "104237  Post-trial Access for Nipocalimab in Participa...   \n",
       "\n",
       "                     Study Status  \\\n",
       "11239   TEMPORARILY_NOT_AVAILABLE   \n",
       "47190   TEMPORARILY_NOT_AVAILABLE   \n",
       "53091   TEMPORARILY_NOT_AVAILABLE   \n",
       "53366   TEMPORARILY_NOT_AVAILABLE   \n",
       "104237  TEMPORARILY_NOT_AVAILABLE   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "11239   Expanded use of Thrombosomes where a clinical ...            NO   \n",
       "47190   This study is designed to multiple dose and do...            NO   \n",
       "53091   R(+) pramipexole dihydrochloride monohydrate \\...            NO   \n",
       "53366   The investigators plan to conduct a first-stag...            NO   \n",
       "104237  The purpose of this post-trial access (PTA) pr...            NO   \n",
       "\n",
       "                              Conditions  \\\n",
       "11239                           Bleeding   \n",
       "47190                            Healthy   \n",
       "53091      Amyotrophic Lateral Sclerosis   \n",
       "53366                Parkinson's Disease   \n",
       "104237  Warm Autoimmune Hemolytic Anemia   \n",
       "\n",
       "                                            Interventions  \\\n",
       "11239                           biological: thrombosomesÂ®   \n",
       "47190                                       drug: hx-1171   \n",
       "53091   drug: r(+) pramipexole dihydrochloride monohyd...   \n",
       "53366                     other: portable motion detector   \n",
       "104237                                  drug: nipocalimab   \n",
       "\n",
       "       Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "11239                   unknown                       none   \n",
       "47190                   unknown                       none   \n",
       "53091                   unknown                       none   \n",
       "53366                   unknown                       none   \n",
       "104237                  unknown                       none   \n",
       "\n",
       "                                    Sponsor  \\\n",
       "11239          Cellphire Therapeutics, Inc.   \n",
       "47190                   Biotoxtech Co., Ltd   \n",
       "53091   Bennett, James P., Jr., M.D., Ph.D.   \n",
       "53366         Far Eastern Memorial Hospital   \n",
       "104237  Janssen Research & Development, LLC   \n",
       "\n",
       "                                          Collaborators      Sex  \\\n",
       "11239                                              none      ALL   \n",
       "47190                                              none     MALE   \n",
       "53091   University of Pittsburgh|University of Nebraska      ALL   \n",
       "53366                                              none      ALL   \n",
       "104237                                             none  unknown   \n",
       "\n",
       "                              Age    Phases  Enrollment Funder Type  \\\n",
       "11239          ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY   \n",
       "47190                       ADULT  NO PHASE          69    INDUSTRY   \n",
       "53091          ADULT, OLDER_ADULT  NO PHASE          69       INDIV   \n",
       "53366   CHILD, ADULT, OLDER_ADULT  NO PHASE          69       OTHER   \n",
       "104237  CHILD, ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY   \n",
       "\n",
       "             Study Type Study Design Start Date Primary Completion Date  \\\n",
       "11239   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "47190   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "53091   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "53366   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "104237  EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "\n",
       "       Completion Date First Posted Last Update Posted  \\\n",
       "11239          unknown   2020-11-06         2022-01-28   \n",
       "47190          unknown   2013-06-28         2013-06-28   \n",
       "53091          unknown   2008-01-16         2012-07-25   \n",
       "53366          unknown   2010-12-20         2010-12-20   \n",
       "104237         unknown   2022-02-03         2024-01-23   \n",
       "\n",
       "                                                Locations  \n",
       "11239                                             unknown  \n",
       "47190   Asan Medical Center, Special City of Seoul, Ko...  \n",
       "53091                                             unknown  \n",
       "53366                                             unknown  \n",
       "104237                                            unknown  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# slice out rows where study status is TEMPORARILY_NOT_AVAILABLE\n",
    "df[df['Study Status'] == 'TEMPORARILY_NOT_AVAILABLE'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6e82c4a6-e3f3-4f37-9d7b-b2a0acd78afb",
   "metadata": {},
   "source": [
    "We can see that the rows where **(Study Status = Temporarily_not_available)** are missing a lot of information in the columns `Outcome_measures`, `Collaborators`, `Study Design`, and some `Locations`. Since this study status is neither completed or terminated, it doesn't provide any meaningful information to the model and we should remove these rows from the dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "d3c80ef3-5086-4615-b3d0-244804094b0b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = temp_not_available\n",
    "df.drop(index = df[df['Study Status'] == 'TEMPORARILY_NOT_AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "5926c856-5111-4d8d-8dde-95b13ed3b0d6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "AVAILABLE                     259\n",
       "APPROVED_FOR_MARKETING        197\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2478d340-5bde-4cb1-8670-d13e3fffef37",
   "metadata": {},
   "source": [
    "Next we should look at `APPROVED_FOR_MARKETING` status, and see where we can group those."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "d506a6db-d46b-4fe7-8ebd-af344d6f65a8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8036</th>\n",
       "      <td>Expanded Access of Pimavanserin for Patients W...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The purpose of this program is to provide pati...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Parkinson's Disease Psychosis</td>\n",
       "      <td>drug: pimavanserin tartrate</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>ACADIA Pharmaceuticals Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2016-05-05</td>\n",
       "      <td>2017-04-18</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8345</th>\n",
       "      <td>18F-FDG PET Imaging in Cardiac Sarcoidosis</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>This study has been designed to provide patien...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiac Sarcoidosis</td>\n",
       "      <td>other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>British Columbia Cancer Agency</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-01-09</td>\n",
       "      <td>2022-02-04</td>\n",
       "      <td>BC Cancer Agency, Vancouver, British Columbia,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8886</th>\n",
       "      <td>Early Access Treatment With Daratumumab for (R...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The objective of this study is to provide earl...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Multiple Myeloma</td>\n",
       "      <td>drug: daratumumab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2015-06-23</td>\n",
       "      <td>2019-01-15</td>\n",
       "      <td>Phoenix, Arizona, United States|Little Rock, A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10306</th>\n",
       "      <td>An Expanded Access Treatment Protocol of Enfor...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The primary purpose of this expanded access pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Locally Advanced or Metastatic Urothelial Carc...</td>\n",
       "      <td>drug: enfortumab vedotin (ev)</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Astellas Pharma Global Development, Inc.</td>\n",
       "      <td>Seagen Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2019-10-23</td>\n",
       "      <td>2020-01-13</td>\n",
       "      <td>UCLA Hematology Oncology, Los Angeles, Califor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11729</th>\n",
       "      <td>An Expanded Access Study to Provide at Home Su...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>This single arm, multicenter study provides th...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HER2-positive Breast Cancer</td>\n",
       "      <td>drug: pertuzumab and trastuzumab fixed-dose co...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Genentech, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-05-20</td>\n",
       "      <td>2022-07-05</td>\n",
       "      <td>Beverly Hills Cancer Center, Beverly Hills, Ca...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             Study Title  \\\n",
       "8036   Expanded Access of Pimavanserin for Patients W...   \n",
       "8345          18F-FDG PET Imaging in Cardiac Sarcoidosis   \n",
       "8886   Early Access Treatment With Daratumumab for (R...   \n",
       "10306  An Expanded Access Treatment Protocol of Enfor...   \n",
       "11729  An Expanded Access Study to Provide at Home Su...   \n",
       "\n",
       "                 Study Status  \\\n",
       "8036   APPROVED_FOR_MARKETING   \n",
       "8345   APPROVED_FOR_MARKETING   \n",
       "8886   APPROVED_FOR_MARKETING   \n",
       "10306  APPROVED_FOR_MARKETING   \n",
       "11729  APPROVED_FOR_MARKETING   \n",
       "\n",
       "                                           Brief Summary Study Results  \\\n",
       "8036   The purpose of this program is to provide pati...            NO   \n",
       "8345   This study has been designed to provide patien...            NO   \n",
       "8886   The objective of this study is to provide earl...            NO   \n",
       "10306  The primary purpose of this expanded access pr...            NO   \n",
       "11729  This single arm, multicenter study provides th...            NO   \n",
       "\n",
       "                                              Conditions  \\\n",
       "8036                       Parkinson's Disease Psychosis   \n",
       "8345                                 Cardiac Sarcoidosis   \n",
       "8886                                    Multiple Myeloma   \n",
       "10306  Locally Advanced or Metastatic Urothelial Carc...   \n",
       "11729                        HER2-positive Breast Cancer   \n",
       "\n",
       "                                           Interventions  \\\n",
       "8036                         drug: pimavanserin tartrate   \n",
       "8345      other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct   \n",
       "8886                                   drug: daratumumab   \n",
       "10306                      drug: enfortumab vedotin (ev)   \n",
       "11729  drug: pertuzumab and trastuzumab fixed-dose co...   \n",
       "\n",
       "      Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "8036                   unknown                       none   \n",
       "8345                   unknown                       none   \n",
       "8886                   unknown                       none   \n",
       "10306                  unknown                       none   \n",
       "11729                  unknown                       none   \n",
       "\n",
       "                                        Sponsor Collaborators  Sex  \\\n",
       "8036                ACADIA Pharmaceuticals Inc.          none  ALL   \n",
       "8345             British Columbia Cancer Agency          none  ALL   \n",
       "8886        Janssen Research & Development, LLC          none  ALL   \n",
       "10306  Astellas Pharma Global Development, Inc.   Seagen Inc.  ALL   \n",
       "11729                           Genentech, Inc.          none  ALL   \n",
       "\n",
       "                      Age    Phases  Enrollment Funder Type       Study Type  \\\n",
       "8036   ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "8345   ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "8886   ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "10306  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "11729  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "\n",
       "      Study Design Start Date Primary Completion Date Completion Date  \\\n",
       "8036       unknown    unknown                 unknown         unknown   \n",
       "8345       unknown    unknown                 unknown         unknown   \n",
       "8886       unknown    unknown                 unknown         unknown   \n",
       "10306      unknown    unknown                 unknown         unknown   \n",
       "11729      unknown    unknown                 unknown         unknown   \n",
       "\n",
       "      First Posted Last Update Posted  \\\n",
       "8036    2016-05-05         2017-04-18   \n",
       "8345    2013-01-09         2022-02-04   \n",
       "8886    2015-06-23         2019-01-15   \n",
       "10306   2019-10-23         2020-01-13   \n",
       "11729   2020-05-20         2022-07-05   \n",
       "\n",
       "                                               Locations  \n",
       "8036                                             unknown  \n",
       "8345   BC Cancer Agency, Vancouver, British Columbia,...  \n",
       "8886   Phoenix, Arizona, United States|Little Rock, A...  \n",
       "10306  UCLA Hematology Oncology, Los Angeles, Califor...  \n",
       "11729  Beverly Hills Cancer Center, Beverly Hills, Ca...  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'APPROVED_FOR_MARKETING'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3431ae3a-277e-44fa-912d-6b12615a4aee",
   "metadata": {},
   "source": [
    "Simiar to the temp_not_available, the category `APPROVED_FOR_MARKETING` is missing a lot of information in the same categories and do not provide much insight into completed or terminated trials. We can drop these rows as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "ad4331cb-f0b4-4c4d-aea9-cd8d8fbaaeba",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = APPROVED_FOR_MARKETING\n",
    "df.drop(index = df[df['Study Status'] == 'APPROVED_FOR_MARKETING'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "7e286b2d-a254-48eb-b522-ba06d07f2659",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "AVAILABLE                     259\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4abf9caa-82b8-4d55-a873-497b1e9fb074",
   "metadata": {},
   "source": [
    "Now, we will look into the `AVAILABLE` category to see where we can group those."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "6b969b46-b334-483b-bfac-23a40dd6f227",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1049</th>\n",
       "      <td>Expanded Access to Ensartinib for Participants...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>This is an open-label, multicenter, intermedia...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-Small Cell Lung Cancer|ALK Gene Rearrangem...</td>\n",
       "      <td>drug: ensartinib</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Xcovery Holdings, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2019-10-31</td>\n",
       "      <td>2022-10-20</td>\n",
       "      <td>Stanford University, Stanford, California, 943...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2621</th>\n",
       "      <td>Intermediate-size Expanded Access Program (EAP...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>The objectives of this intermediate-size expan...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Multisystem Inflammatory Syndrome in Children ...</td>\n",
       "      <td>biological: remestemcel-l|drug: hydrocortisone...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Mesoblast International SÃ rl</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-07-02</td>\n",
       "      <td>2023-05-06</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3931</th>\n",
       "      <td>Chronic Effect of Mat Pilates on Neuromotor, C...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>The Pilates method aims to develop conscious c...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Stroke|High Blood Pressure</td>\n",
       "      <td>other: mat pilates</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Rio de Janeiro State University</td>\n",
       "      <td>Postgraduate scholarship</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2024-02-05</td>\n",
       "      <td>2024-02-14</td>\n",
       "      <td>Jeferson Silva da Rocha, Rio De Janeiro, 20550...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6425</th>\n",
       "      <td>Chelated Oral Iron Versus Intravenous Iron Suc...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>compare the efficacy and safety of intravenous...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Iron Deficiency Anemia of Pregnancy</td>\n",
       "      <td>drug: chelated iron|drug: iron sucrose</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Assiut University</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2021-12-09</td>\n",
       "      <td>2021-12-09</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7385</th>\n",
       "      <td>A Cohort IND Expanded Access Program for Suppo...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>This Expanded Access Program aims to:\\n\\n1. Pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Uveal Melanoma</td>\n",
       "      <td>drug: tebentafusp</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Immunocore Ltd</td>\n",
       "      <td>Clinigen, Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>2022-01-21</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Study Title Study Status  \\\n",
       "1049  Expanded Access to Ensartinib for Participants...    AVAILABLE   \n",
       "2621  Intermediate-size Expanded Access Program (EAP...    AVAILABLE   \n",
       "3931  Chronic Effect of Mat Pilates on Neuromotor, C...    AVAILABLE   \n",
       "6425  Chelated Oral Iron Versus Intravenous Iron Suc...    AVAILABLE   \n",
       "7385  A Cohort IND Expanded Access Program for Suppo...    AVAILABLE   \n",
       "\n",
       "                                          Brief Summary Study Results  \\\n",
       "1049  This is an open-label, multicenter, intermedia...            NO   \n",
       "2621  The objectives of this intermediate-size expan...            NO   \n",
       "3931  The Pilates method aims to develop conscious c...            NO   \n",
       "6425  compare the efficacy and safety of intravenous...            NO   \n",
       "7385  This Expanded Access Program aims to:\\n\\n1. Pr...            NO   \n",
       "\n",
       "                                             Conditions  \\\n",
       "1049  Non-Small Cell Lung Cancer|ALK Gene Rearrangem...   \n",
       "2621  Multisystem Inflammatory Syndrome in Children ...   \n",
       "3931                         Stroke|High Blood Pressure   \n",
       "6425                Iron Deficiency Anemia of Pregnancy   \n",
       "7385                                     Uveal Melanoma   \n",
       "\n",
       "                                          Interventions  \\\n",
       "1049                                   drug: ensartinib   \n",
       "2621  biological: remestemcel-l|drug: hydrocortisone...   \n",
       "3931                                 other: mat pilates   \n",
       "6425             drug: chelated iron|drug: iron sucrose   \n",
       "7385                                  drug: tebentafusp   \n",
       "\n",
       "     Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "1049                  unknown                       none   \n",
       "2621                  unknown                       none   \n",
       "3931                  unknown                       none   \n",
       "6425                  unknown                       none   \n",
       "7385                  unknown                       none   \n",
       "\n",
       "                              Sponsor             Collaborators     Sex  \\\n",
       "1049           Xcovery Holdings, Inc.                      none     ALL   \n",
       "2621     Mesoblast International SÃ rl                      none     ALL   \n",
       "3931  Rio de Janeiro State University  Postgraduate scholarship     ALL   \n",
       "6425                Assiut University                      none  FEMALE   \n",
       "7385                   Immunocore Ltd            Clinigen, Inc.     ALL   \n",
       "\n",
       "                     Age    Phases  Enrollment Funder Type       Study Type  \\\n",
       "1049  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "2621               CHILD  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "3931  ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "6425  ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "7385  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "\n",
       "     Study Design Start Date Primary Completion Date Completion Date  \\\n",
       "1049      unknown    unknown                 unknown         unknown   \n",
       "2621      unknown    unknown                 unknown         unknown   \n",
       "3931      unknown    unknown                 unknown         unknown   \n",
       "6425      unknown    unknown                 unknown         unknown   \n",
       "7385      unknown    unknown                 unknown         unknown   \n",
       "\n",
       "     First Posted Last Update Posted  \\\n",
       "1049   2019-10-31         2022-10-20   \n",
       "2621   2020-07-02         2023-05-06   \n",
       "3931   2024-02-05         2024-02-14   \n",
       "6425   2021-12-09         2021-12-09   \n",
       "7385   2021-07-14         2022-01-21   \n",
       "\n",
       "                                              Locations  \n",
       "1049  Stanford University, Stanford, California, 943...  \n",
       "2621                                            unknown  \n",
       "3931  Jeferson Silva da Rocha, Rio De Janeiro, 20550...  \n",
       "6425                                            unknown  \n",
       "7385                                            unknown  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'AVAILABLE'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8dc5b63f-d0b9-4717-bdce-e2e1435eaf4e",
   "metadata": {},
   "source": [
    "These are the studies that are now available. However, this category is missing `Study Design`, some `Collaborators`, and `Outcome_measures`. These studies could still be waiting for more information to be filled in, so for now we will remove these rows as they will not affect our prediction model."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "0c0f998a-a6c7-4908-8440-cf5f7fd61b17",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = AVAILABLE\n",
    "df.drop(index = df[df['Study Status'] == 'AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "5116b7ec-fa2a-4ef6-ab1d-8939990c04fe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1c021259-28c2-40ae-a65f-0c5134b1fd83",
   "metadata": {},
   "source": [
    "The `NO_LONGER_AVAILABLE` status has 446 studies, let's see where we can group these."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "c8fbeb30-db67-4d3e-83b6-b6936e2a6809",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>323743</th>\n",
       "      <td>Use Of 3,4-Diaminopyridine (3,4-DAP) In The Tr...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>Compassionate use of orphan drug 3,4-Diaminopy...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Lambert-Eaton Myasthenic Syndrome</td>\n",
       "      <td>drug: 3,4 dap</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>The Cleveland Clinic</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1997-09</td>\n",
       "      <td>2012-09</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2011-06-14</td>\n",
       "      <td>2016-07-20</td>\n",
       "      <td>Cleveland Clinic Foundation, Cleveland, Ohio, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337080</th>\n",
       "      <td>EAP for the Treatment of Glioblastoma With PVS...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>This is an open-label, single-arm, non-randomi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Glioblastoma</td>\n",
       "      <td>biological: pvsripo</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Istari Oncology, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-10-23</td>\n",
       "      <td>2022-06-29</td>\n",
       "      <td>Duke University Medical Center, Durham, North ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426088</th>\n",
       "      <td>Compassionate Use of MitoGel in Upper Tract Ur...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>The aim of this study is to evaluate the feasi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Urothelial Carcinoma Ureteral Location</td>\n",
       "      <td>drug: mitogel</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Jonsson Comprehensive Cancer Center</td>\n",
       "      <td>UroGen Pharma Ltd.</td>\n",
       "      <td>MALE</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2016-03-07</td>\n",
       "      <td>2017-09-14</td>\n",
       "      <td>UCLA, Los Angeles, California, 90024, United S...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399410</th>\n",
       "      <td>Clinical Management Decisions for Recurrent Pr...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>When evaluating prostate cancer patients for r...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>drug: [11c]acetate</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Wendell Yap, MD</td>\n",
       "      <td>University of Kansas Medical Center</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-01-28</td>\n",
       "      <td>2018-05-16</td>\n",
       "      <td>University of Kansas Medical Center, Kansas Ci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179355</th>\n",
       "      <td>Defibrotide Compassionate Use for Patients Wit...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>Severe veno-occlusive disease (VOD) of the liv...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Liver Diseases</td>\n",
       "      <td>drug: defibrotide</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Emory University</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2005-11</td>\n",
       "      <td>2009-06</td>\n",
       "      <td>2009-06</td>\n",
       "      <td>2005-12-12</td>\n",
       "      <td>2014-07-01</td>\n",
       "      <td>Children's Healthcare of Atlanta, Atlanta, Geo...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "323743  Use Of 3,4-Diaminopyridine (3,4-DAP) In The Tr...   \n",
       "337080  EAP for the Treatment of Glioblastoma With PVS...   \n",
       "426088  Compassionate Use of MitoGel in Upper Tract Ur...   \n",
       "399410  Clinical Management Decisions for Recurrent Pr...   \n",
       "179355  Defibrotide Compassionate Use for Patients Wit...   \n",
       "\n",
       "               Study Status  \\\n",
       "323743  NO_LONGER_AVAILABLE   \n",
       "337080  NO_LONGER_AVAILABLE   \n",
       "426088  NO_LONGER_AVAILABLE   \n",
       "399410  NO_LONGER_AVAILABLE   \n",
       "179355  NO_LONGER_AVAILABLE   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "323743  Compassionate use of orphan drug 3,4-Diaminopy...            NO   \n",
       "337080  This is an open-label, single-arm, non-randomi...            NO   \n",
       "426088  The aim of this study is to evaluate the feasi...            NO   \n",
       "399410  When evaluating prostate cancer patients for r...            NO   \n",
       "179355  Severe veno-occlusive disease (VOD) of the liv...            NO   \n",
       "\n",
       "                                    Conditions        Interventions  \\\n",
       "323743       Lambert-Eaton Myasthenic Syndrome        drug: 3,4 dap   \n",
       "337080                            Glioblastoma  biological: pvsripo   \n",
       "426088  Urothelial Carcinoma Ureteral Location        drug: mitogel   \n",
       "399410                         Prostate Cancer   drug: [11c]acetate   \n",
       "179355                          Liver Diseases    drug: defibrotide   \n",
       "\n",
       "       Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "323743                  unknown                       none   \n",
       "337080                  unknown                       none   \n",
       "426088                  unknown                       none   \n",
       "399410                  unknown                       none   \n",
       "179355                  unknown                       none   \n",
       "\n",
       "                                    Sponsor  \\\n",
       "323743                 The Cleveland Clinic   \n",
       "337080                Istari Oncology, Inc.   \n",
       "426088  Jonsson Comprehensive Cancer Center   \n",
       "399410                      Wendell Yap, MD   \n",
       "179355                     Emory University   \n",
       "\n",
       "                              Collaborators   Sex                 Age  \\\n",
       "323743                                 none   ALL  ADULT, OLDER_ADULT   \n",
       "337080                                 none   ALL  ADULT, OLDER_ADULT   \n",
       "426088                   UroGen Pharma Ltd.  MALE         OLDER_ADULT   \n",
       "399410  University of Kansas Medical Center  MALE  ADULT, OLDER_ADULT   \n",
       "179355                                 none   ALL        CHILD, ADULT   \n",
       "\n",
       "          Phases  Enrollment Funder Type       Study Type Study Design  \\\n",
       "323743  NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "337080  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS      unknown   \n",
       "426088  NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "399410  NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "179355  NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "\n",
       "       Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "323743    1997-09                 2012-09         unknown   2011-06-14   \n",
       "337080    unknown                 unknown         unknown   2020-10-23   \n",
       "426088    unknown                 unknown         unknown   2016-03-07   \n",
       "399410    unknown                 unknown         unknown   2013-01-28   \n",
       "179355    2005-11                 2009-06         2009-06   2005-12-12   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "323743         2016-07-20  Cleveland Clinic Foundation, Cleveland, Ohio, ...  \n",
       "337080         2022-06-29  Duke University Medical Center, Durham, North ...  \n",
       "426088         2017-09-14  UCLA, Los Angeles, California, 90024, United S...  \n",
       "399410         2018-05-16  University of Kansas Medical Center, Kansas Ci...  \n",
       "179355         2014-07-01  Children's Healthcare of Atlanta, Atlanta, Geo...  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'NO_LONGER_AVAILABLE'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7326a1af-b3c9-47cd-bf40-1fbe0af1956d",
   "metadata": {},
   "source": [
    "Similarly with the AVAILABLE status, this category is missing information from `outcome_measures`, some `collaborators`, `Phases`, and `Study design`. We can remove these rows as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "f948d9fd-d14f-4340-8f83-afcbf9fb408c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = NO_LONGER_AVAILABLE\n",
    "df.drop(index = df[df['Study Status'] == 'NO_LONGER_AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "6fc7229b-413c-4421-8989-a3cec6d48477",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ad5142b1-9f0f-44c2-b18b-62c7eede0585",
   "metadata": {},
   "source": [
    "The suspended status is when studies are halted for an indefinite amount of time, but can resume when proper conditions are met. Let's see where we can group these statuses."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "4efa25e1-6ad2-4811-b487-3c9aaeb097a3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>190035</th>\n",
       "      <td>A Study Evaluating Safety and Efficacy of BIOD...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>The purpose of this study is to evaluate the s...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Diabetes Mellitus</td>\n",
       "      <td>drug: biod-531|drug: humalogÂ® mix 75/25</td>\n",
       "      <td>Change in HbA1c, 18 weeks</td>\n",
       "      <td>Postprandial glucose excursions, 18 weeks|Chan...</td>\n",
       "      <td>Biodel</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>13</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2015-05</td>\n",
       "      <td>2016-02</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2015-05-15</td>\n",
       "      <td>2016-04-07</td>\n",
       "      <td>Meridien Research, Bradenton, Florida, 34208, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91361</th>\n",
       "      <td>Study to Evaluate the Effectiveness and Safety...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>The purpose of this study is to evaluate the e...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Female Sexual Interest/Arousal Disorder</td>\n",
       "      <td>dietary_supplement: libicare|dietary_supplemen...</td>\n",
       "      <td>Evolution of sexual desire and arousal, The ev...</td>\n",
       "      <td>The evolution of the composite score from sexu...</td>\n",
       "      <td>Procare Health Iberia S.L.</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>120</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2023-10-01</td>\n",
       "      <td>2023-10-01</td>\n",
       "      <td>2023-12-01</td>\n",
       "      <td>2019-12-06</td>\n",
       "      <td>2023-11-24</td>\n",
       "      <td>Procare Health Iberia, Castelldefels, Barcelon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370118</th>\n",
       "      <td>A Multicenter, Randomized, Double-blind, Place...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>To demonstrate the superior effect of ES135 co...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Spinal Cord Injuries</td>\n",
       "      <td>drug: es135</td>\n",
       "      <td>Mean change of International Standards for Neu...</td>\n",
       "      <td>none</td>\n",
       "      <td>Eusol Biotech Co., Ltd.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>160</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-03-07</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>2026-12-31</td>\n",
       "      <td>2017-07-25</td>\n",
       "      <td>2023-04-24</td>\n",
       "      <td>Kaohsiung Veterans General Hospital, Kaohsiung...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44590</th>\n",
       "      <td>Computed Optical Margin Assessment for Breast ...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>This intraoperative study is a prospective stu...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>device: interferometric synthetic aperture mic...</td>\n",
       "      <td>Patients With All Positive/Close Margins Corre...</td>\n",
       "      <td>none</td>\n",
       "      <td>Diagnostic Photonics, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>50</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2014-04</td>\n",
       "      <td>2020-02</td>\n",
       "      <td>2020-03-18</td>\n",
       "      <td>2014-12-09</td>\n",
       "      <td>2019-07-18</td>\n",
       "      <td>Johns Hopkins Hospital, Baltimore, Maryland, 2...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333144</th>\n",
       "      <td>Effect of the High Impact Exercise on Bone Den...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>Osteoporosis has become a worldwide concern an...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Bone Loss, Age-Related,</td>\n",
       "      <td>other: high impact exercise|other: low impact ...</td>\n",
       "      <td>bone mineral density (BMD) are presented for t...</td>\n",
       "      <td>none</td>\n",
       "      <td>FundaciÃ³n Santa Fe de Bogota</td>\n",
       "      <td>Instituto Colombiano para el Desarrollo de la ...</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>276</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2016-02</td>\n",
       "      <td>2016-11</td>\n",
       "      <td>2017-05</td>\n",
       "      <td>2015-07-02</td>\n",
       "      <td>2016-02-11</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "190035  A Study Evaluating Safety and Efficacy of BIOD...    SUSPENDED   \n",
       "91361   Study to Evaluate the Effectiveness and Safety...    SUSPENDED   \n",
       "370118  A Multicenter, Randomized, Double-blind, Place...    SUSPENDED   \n",
       "44590   Computed Optical Margin Assessment for Breast ...    SUSPENDED   \n",
       "333144  Effect of the High Impact Exercise on Bone Den...    SUSPENDED   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "190035  The purpose of this study is to evaluate the s...            NO   \n",
       "91361   The purpose of this study is to evaluate the e...            NO   \n",
       "370118  To demonstrate the superior effect of ES135 co...            NO   \n",
       "44590   This intraoperative study is a prospective stu...            NO   \n",
       "333144  Osteoporosis has become a worldwide concern an...            NO   \n",
       "\n",
       "                                     Conditions  \\\n",
       "190035                        Diabetes Mellitus   \n",
       "91361   Female Sexual Interest/Arousal Disorder   \n",
       "370118                     Spinal Cord Injuries   \n",
       "44590                             Breast Cancer   \n",
       "333144                  Bone Loss, Age-Related,   \n",
       "\n",
       "                                            Interventions  \\\n",
       "190035            drug: biod-531|drug: humalogÂ® mix 75/25   \n",
       "91361   dietary_supplement: libicare|dietary_supplemen...   \n",
       "370118                                        drug: es135   \n",
       "44590   device: interferometric synthetic aperture mic...   \n",
       "333144  other: high impact exercise|other: low impact ...   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "190035                          Change in HbA1c, 18 weeks   \n",
       "91361   Evolution of sexual desire and arousal, The ev...   \n",
       "370118  Mean change of International Standards for Neu...   \n",
       "44590   Patients With All Positive/Close Margins Corre...   \n",
       "333144  bone mineral density (BMD) are presented for t...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "190035  Postprandial glucose excursions, 18 weeks|Chan...   \n",
       "91361   The evolution of the composite score from sexu...   \n",
       "370118                                               none   \n",
       "44590                                                none   \n",
       "333144                                               none   \n",
       "\n",
       "                             Sponsor  \\\n",
       "190035                        Biodel   \n",
       "91361     Procare Health Iberia S.L.   \n",
       "370118       Eusol Biotech Co., Ltd.   \n",
       "44590     Diagnostic Photonics, Inc.   \n",
       "333144  FundaciÃ³n Santa Fe de Bogota   \n",
       "\n",
       "                                            Collaborators     Sex  \\\n",
       "190035                                               none     ALL   \n",
       "91361                                                none  FEMALE   \n",
       "370118                                               none     ALL   \n",
       "44590                                                none  FEMALE   \n",
       "333144  Instituto Colombiano para el Desarrollo de la ...  FEMALE   \n",
       "\n",
       "                              Age    Phases  Enrollment Funder Type  \\\n",
       "190035         ADULT, OLDER_ADULT    PHASE2          13    INDUSTRY   \n",
       "91361          ADULT, OLDER_ADULT  NO PHASE         120    INDUSTRY   \n",
       "370118  CHILD, ADULT, OLDER_ADULT    PHASE3         160    INDUSTRY   \n",
       "44590          ADULT, OLDER_ADULT  NO PHASE          50    INDUSTRY   \n",
       "333144                      CHILD  NO PHASE         276       OTHER   \n",
       "\n",
       "            Study Type                                       Study Design  \\\n",
       "190035  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "91361   INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "370118  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "44590    OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "333144  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "        Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "190035     2015-05                 2016-02         2016-05   2015-05-15   \n",
       "91361   2023-10-01              2023-10-01      2023-12-01   2019-12-06   \n",
       "370118  2018-03-07              2024-12-31      2026-12-31   2017-07-25   \n",
       "44590      2014-04                 2020-02      2020-03-18   2014-12-09   \n",
       "333144     2016-02                 2016-11         2017-05   2015-07-02   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "190035         2016-04-07  Meridien Research, Bradenton, Florida, 34208, ...  \n",
       "91361          2023-11-24  Procare Health Iberia, Castelldefels, Barcelon...  \n",
       "370118         2023-04-24  Kaohsiung Veterans General Hospital, Kaohsiung...  \n",
       "44590          2019-07-18  Johns Hopkins Hospital, Baltimore, Maryland, 2...  \n",
       "333144         2016-02-11                                            unknown  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'SUSPENDED'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "72c09a70-e690-42b3-a14a-1f792e418264",
   "metadata": {},
   "source": [
    "If we look at the `Completion Date` column, we can see that some dates are set in the future (2025, 2028, etc). This means that these studies could potentially startup again when conditions are met. Therefore, we should remove these rows since they are neither completed or terminated."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "0733e46b-0fa8-4a4b-be37-bf83e09c2cb3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = SUSPENDED\n",
    "df.drop(index = df[df['Study Status'] == 'SUSPENDED'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "eece0f00-039e-4fb0-a807-049ddf776203",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b156f067-1e0c-40e3-af86-1f7087a42bb8",
   "metadata": {},
   "source": [
    "Now let's look at `ENROLLING_BY_INVITATION` to see where we can group these statuses with."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "d851e8aa-25c0-4f82-884c-48c72bf223ab",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>372308</th>\n",
       "      <td>PCSK9 Inhibition After Heart Transplantation</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The focus of this study is to test the safety ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Vasculopathy</td>\n",
       "      <td>biological: alirocumab|biological: placebo</td>\n",
       "      <td>Change in volume of plaque at 1 year post stud...</td>\n",
       "      <td>Change in LDL-C, measure differences in LDL-C ...</td>\n",
       "      <td>Stanford University</td>\n",
       "      <td>National Heart, Lung, and Blood Institute (NHLBI)</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>120</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2019-05-13</td>\n",
       "      <td>2025-02-28</td>\n",
       "      <td>2025-02-28</td>\n",
       "      <td>2018-05-25</td>\n",
       "      <td>2023-11-28</td>\n",
       "      <td>Stanford University, Stanford, California, 943...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271785</th>\n",
       "      <td>Implementation and Evaluation of A Health Inno...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The goal of this stepped wedge pragmatic trial...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Care Transitions</td>\n",
       "      <td>behavioral: thrive intervention</td>\n",
       "      <td>Rates of Referrals to Homecare, We will evalua...</td>\n",
       "      <td>Feasibility, Acceptability, Appropriateness, W...</td>\n",
       "      <td>University of Pennsylvania</td>\n",
       "      <td>Rita &amp; Alex Hillman Foundation</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>267</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2023-03-27</td>\n",
       "      <td>2024-05-27</td>\n",
       "      <td>2024-12-30</td>\n",
       "      <td>2023-02-06</td>\n",
       "      <td>2023-04-07</td>\n",
       "      <td>Pennsylvania Hospital, Philadelphia, Pennsylva...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438844</th>\n",
       "      <td>Multimodal Noninvasive Assessment of Periphera...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>Assessment of a novel diagnostic method for sc...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Chronic Limb Threatening Ischemia</td>\n",
       "      <td>unknown</td>\n",
       "      <td>Perfusion in lower limb angiosomes assessed by...</td>\n",
       "      <td>none</td>\n",
       "      <td>Tampere University</td>\n",
       "      <td>Tampere University Hospital</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>150</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2023-04-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2024-02-01</td>\n",
       "      <td>2023-03-27</td>\n",
       "      <td>2023-03-27</td>\n",
       "      <td>Tampere University, Tampere, Pirkanmaa, 33720,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>397526</th>\n",
       "      <td>The Feasibility of Home-Based Measurement of C...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>Veterans with traumatic brain injury (TBI) fre...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Brain Injuries, Traumatic|Sleep Initiation and...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>Feasibility of Home Dim Light Melatonin Onset ...</td>\n",
       "      <td>Functional Impairment (WHODAS 2.0 Summary Scor...</td>\n",
       "      <td>VA Office of Research and Development</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>56</td>\n",
       "      <td>FED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2023-07-01</td>\n",
       "      <td>2025-03-31</td>\n",
       "      <td>2025-06-30</td>\n",
       "      <td>2022-12-27</td>\n",
       "      <td>2023-08-01</td>\n",
       "      <td>Rocky Mountain Regional VA Medical Center, Aur...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53753</th>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The purpose of this First-in-Human study is to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>IPF</td>\n",
       "      <td>drug: hnc1058 capsules</td>\n",
       "      <td>Number of subjects with adverse events and con...</td>\n",
       "      <td>Number of subjects with vital sign measurement...</td>\n",
       "      <td>Guangzhou Henovcom Bioscience Co. Ltd.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>32</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SEQ...</td>\n",
       "      <td>2023-03-28</td>\n",
       "      <td>2024-03-27</td>\n",
       "      <td>2024-03-27</td>\n",
       "      <td>2023-04-07</td>\n",
       "      <td>2024-01-03</td>\n",
       "      <td>Syneos Health, Miami, Florida, 33136, United S...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "372308       PCSK9 Inhibition After Heart Transplantation   \n",
       "271785  Implementation and Evaluation of A Health Inno...   \n",
       "438844  Multimodal Noninvasive Assessment of Periphera...   \n",
       "397526  The Feasibility of Home-Based Measurement of C...   \n",
       "53753   A Study to Evaluate the Safety, Tolerability, ...   \n",
       "\n",
       "                   Study Status  \\\n",
       "372308  ENROLLING_BY_INVITATION   \n",
       "271785  ENROLLING_BY_INVITATION   \n",
       "438844  ENROLLING_BY_INVITATION   \n",
       "397526  ENROLLING_BY_INVITATION   \n",
       "53753   ENROLLING_BY_INVITATION   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "372308  The focus of this study is to test the safety ...            NO   \n",
       "271785  The goal of this stepped wedge pragmatic trial...            NO   \n",
       "438844  Assessment of a novel diagnostic method for sc...            NO   \n",
       "397526  Veterans with traumatic brain injury (TBI) fre...            NO   \n",
       "53753   The purpose of this First-in-Human study is to...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "372308                                       Vasculopathy   \n",
       "271785                                   Care Transitions   \n",
       "438844                  Chronic Limb Threatening Ischemia   \n",
       "397526  Brain Injuries, Traumatic|Sleep Initiation and...   \n",
       "53753                                                 IPF   \n",
       "\n",
       "                                     Interventions  \\\n",
       "372308  biological: alirocumab|biological: placebo   \n",
       "271785             behavioral: thrive intervention   \n",
       "438844                                     unknown   \n",
       "397526                                     unknown   \n",
       "53753                       drug: hnc1058 capsules   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "372308  Change in volume of plaque at 1 year post stud...   \n",
       "271785  Rates of Referrals to Homecare, We will evalua...   \n",
       "438844  Perfusion in lower limb angiosomes assessed by...   \n",
       "397526  Feasibility of Home Dim Light Melatonin Onset ...   \n",
       "53753   Number of subjects with adverse events and con...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "372308  Change in LDL-C, measure differences in LDL-C ...   \n",
       "271785  Feasibility, Acceptability, Appropriateness, W...   \n",
       "438844                                               none   \n",
       "397526  Functional Impairment (WHODAS 2.0 Summary Scor...   \n",
       "53753   Number of subjects with vital sign measurement...   \n",
       "\n",
       "                                       Sponsor  \\\n",
       "372308                     Stanford University   \n",
       "271785              University of Pennsylvania   \n",
       "438844                      Tampere University   \n",
       "397526   VA Office of Research and Development   \n",
       "53753   Guangzhou Henovcom Bioscience Co. Ltd.   \n",
       "\n",
       "                                            Collaborators  Sex  \\\n",
       "372308  National Heart, Lung, and Blood Institute (NHLBI)  ALL   \n",
       "271785                     Rita & Alex Hillman Foundation  ALL   \n",
       "438844                        Tampere University Hospital  ALL   \n",
       "397526                                               none  ALL   \n",
       "53753                                                none  ALL   \n",
       "\n",
       "                       Age    Phases  Enrollment Funder Type      Study Type  \\\n",
       "372308  ADULT, OLDER_ADULT    PHASE2         120       OTHER  INTERVENTIONAL   \n",
       "271785  ADULT, OLDER_ADULT  NO PHASE         267       OTHER  INTERVENTIONAL   \n",
       "438844  ADULT, OLDER_ADULT  NO PHASE         150       OTHER   OBSERVATIONAL   \n",
       "397526               ADULT  NO PHASE          56         FED   OBSERVATIONAL   \n",
       "53753                ADULT    PHASE1          32    INDUSTRY  INTERVENTIONAL   \n",
       "\n",
       "                                             Study Design  Start Date  \\\n",
       "372308  Allocation: RANDOMIZED|Intervention Model: PAR...  2019-05-13   \n",
       "271785  Allocation: RANDOMIZED|Intervention Model: PAR...  2023-03-27   \n",
       "438844          Observational Model: |Time Perspective: p  2023-04-01   \n",
       "397526          Observational Model: |Time Perspective: p  2023-07-01   \n",
       "53753   Allocation: RANDOMIZED|Intervention Model: SEQ...  2023-03-28   \n",
       "\n",
       "       Primary Completion Date Completion Date First Posted  \\\n",
       "372308              2025-02-28      2025-02-28   2018-05-25   \n",
       "271785              2024-05-27      2024-12-30   2023-02-06   \n",
       "438844              2023-04-30      2024-02-01   2023-03-27   \n",
       "397526              2025-03-31      2025-06-30   2022-12-27   \n",
       "53753               2024-03-27      2024-03-27   2023-04-07   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "372308         2023-11-28  Stanford University, Stanford, California, 943...  \n",
       "271785         2023-04-07  Pennsylvania Hospital, Philadelphia, Pennsylva...  \n",
       "438844         2023-03-27  Tampere University, Tampere, Pirkanmaa, 33720,...  \n",
       "397526         2023-08-01  Rocky Mountain Regional VA Medical Center, Aur...  \n",
       "53753          2024-01-03  Syneos Health, Miami, Florida, 33136, United S...  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'ENROLLING_BY_INVITATION'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3471d96f-2966-4605-926f-950cbe87c777",
   "metadata": {},
   "source": [
    "The `ENROLLING_BY_INVITATION` status consists of studies that are currently selecting participants from a predetermine population for the research. Since this status is not within our scope of the problem, we can also remove these rows."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "526897d0-3768-4b13-8720-cb43cb9d8e11",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = `ENROLLING_BY_INVITATION`\n",
    "df.drop(index = df[df['Study Status'] == 'ENROLLING_BY_INVITATION'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "61bebed5-9fc8-46aa-be62-001594d5edb6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                263380\n",
       "RECRUITING                66150\n",
       "UNKNOWN                   64828\n",
       "TERMINATED                28014\n",
       "NOT_YET_RECRUITING        20055\n",
       "ACTIVE_NOT_RECRUITING     19702\n",
       "WITHDRAWN                 13716\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cdd79bd2-bb74-440d-b94b-4049975af40f",
   "metadata": {},
   "source": [
    "Next we will look at the `WITHDRAWN` status which has 13,716 studies."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "5447b29a-438c-436b-81e5-83fcb2b27ef1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>240609</th>\n",
       "      <td>Efficacy of Reza Band for the Treatment of Lar...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>We hypothesize that tissue and salivary pepsin...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Laryngopharyngeal Reflux</td>\n",
       "      <td>device: reza band</td>\n",
       "      <td>Change in Tissue and Salivary Pepsin Levels, T...</td>\n",
       "      <td>none</td>\n",
       "      <td>Medical College of Wisconsin</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2020-07</td>\n",
       "      <td>2021-11</td>\n",
       "      <td>2021-11</td>\n",
       "      <td>2018-03-13</td>\n",
       "      <td>2020-05-08</td>\n",
       "      <td>Froedtert Hospital and Medical College of Wisc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387083</th>\n",
       "      <td>A Comparison of Fixation Method in Total Knee ...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The purpose of this study is to compare the ea...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Osteoarthritis</td>\n",
       "      <td>device: osteopal g vs. refobacin-palacos r bon...</td>\n",
       "      <td>Tibial prosthesis part migration evaluated by ...</td>\n",
       "      <td>Micromotion of the modular polyethylen liner i...</td>\n",
       "      <td>University of Aarhus</td>\n",
       "      <td>Aarhus University Hospital|Zimmer Biomet</td>\n",
       "      <td>ALL</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2010-12</td>\n",
       "      <td>2005-09-15</td>\n",
       "      <td>2022-12-19</td>\n",
       "      <td>Orthopaedic Center, Aarhus University Hospital...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190858</th>\n",
       "      <td>Response of Gut Microbiota and Cardiometabolic...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The researchers will investigate blood and fec...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Healthy|Normal Weight|Overweight|Obese</td>\n",
       "      <td>other: walnut|other: nut-free</td>\n",
       "      <td>Assessing the influence of walnuts on the feca...</td>\n",
       "      <td>Assessing the influence of walnuts on blood li...</td>\n",
       "      <td>University of California, Davis</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2022-06-01</td>\n",
       "      <td>2024-03-31</td>\n",
       "      <td>2024-11-30</td>\n",
       "      <td>2020-03-13</td>\n",
       "      <td>2023-09-18</td>\n",
       "      <td>Ragle Human Nutrition Research Center, Davis, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>320731</th>\n",
       "      <td>Coronary Bifurcation Lesions Treated With Bigu...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>This study is designed to test the hypothesis ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Coronary Artery Disease</td>\n",
       "      <td>device: biguard sirolimus-eluting bifurcation ...</td>\n",
       "      <td>Incidence of Ischemia Driven Target Lesion Fai...</td>\n",
       "      <td>In-stent late lumen loss in millimeter, In-ste...</td>\n",
       "      <td>Nanjing First Hospital, Nanjing Medical Univer...</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2015-12</td>\n",
       "      <td>2015-12</td>\n",
       "      <td>2015-12</td>\n",
       "      <td>2015-11-05</td>\n",
       "      <td>2017-12-06</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301789</th>\n",
       "      <td>INTERCEPT Safety Evaluation in Anemic Patients</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The pathogen reduction (PR) system for Whole B...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Anemia</td>\n",
       "      <td>device: intercept|device: standard of care</td>\n",
       "      <td>Severe Transfusion Reactions, The primary safe...</td>\n",
       "      <td>Adverse events, All adverse events including a...</td>\n",
       "      <td>Swiss Transfusion SRC</td>\n",
       "      <td>Cerus Corporation</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2019-06</td>\n",
       "      <td>2020-03</td>\n",
       "      <td>2020-06</td>\n",
       "      <td>2018-04-03</td>\n",
       "      <td>2019-12-13</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "240609  Efficacy of Reza Band for the Treatment of Lar...    WITHDRAWN   \n",
       "387083  A Comparison of Fixation Method in Total Knee ...    WITHDRAWN   \n",
       "190858  Response of Gut Microbiota and Cardiometabolic...    WITHDRAWN   \n",
       "320731  Coronary Bifurcation Lesions Treated With Bigu...    WITHDRAWN   \n",
       "301789     INTERCEPT Safety Evaluation in Anemic Patients    WITHDRAWN   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "240609  We hypothesize that tissue and salivary pepsin...            NO   \n",
       "387083  The purpose of this study is to compare the ea...            NO   \n",
       "190858  The researchers will investigate blood and fec...            NO   \n",
       "320731  This study is designed to test the hypothesis ...            NO   \n",
       "301789  The pathogen reduction (PR) system for Whole B...            NO   \n",
       "\n",
       "                                    Conditions  \\\n",
       "240609                Laryngopharyngeal Reflux   \n",
       "387083                          Osteoarthritis   \n",
       "190858  Healthy|Normal Weight|Overweight|Obese   \n",
       "320731                 Coronary Artery Disease   \n",
       "301789                                  Anemia   \n",
       "\n",
       "                                            Interventions  \\\n",
       "240609                                  device: reza band   \n",
       "387083  device: osteopal g vs. refobacin-palacos r bon...   \n",
       "190858                      other: walnut|other: nut-free   \n",
       "320731  device: biguard sirolimus-eluting bifurcation ...   \n",
       "301789         device: intercept|device: standard of care   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "240609  Change in Tissue and Salivary Pepsin Levels, T...   \n",
       "387083  Tibial prosthesis part migration evaluated by ...   \n",
       "190858  Assessing the influence of walnuts on the feca...   \n",
       "320731  Incidence of Ischemia Driven Target Lesion Fai...   \n",
       "301789  Severe Transfusion Reactions, The primary safe...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "240609                                               none   \n",
       "387083  Micromotion of the modular polyethylen liner i...   \n",
       "190858  Assessing the influence of walnuts on blood li...   \n",
       "320731  In-stent late lumen loss in millimeter, In-ste...   \n",
       "301789  Adverse events, All adverse events including a...   \n",
       "\n",
       "                                                  Sponsor  \\\n",
       "240609                       Medical College of Wisconsin   \n",
       "387083                               University of Aarhus   \n",
       "190858                    University of California, Davis   \n",
       "320731  Nanjing First Hospital, Nanjing Medical Univer...   \n",
       "301789                              Swiss Transfusion SRC   \n",
       "\n",
       "                                   Collaborators  Sex                 Age  \\\n",
       "240609                                      none  ALL  ADULT, OLDER_ADULT   \n",
       "387083  Aarhus University Hospital|Zimmer Biomet  ALL         OLDER_ADULT   \n",
       "190858                                      none  ALL  ADULT, OLDER_ADULT   \n",
       "320731                                      none  ALL  ADULT, OLDER_ADULT   \n",
       "301789                         Cerus Corporation  ALL  ADULT, OLDER_ADULT   \n",
       "\n",
       "          Phases  Enrollment Funder Type      Study Type  \\\n",
       "240609  NO PHASE           0       OTHER  INTERVENTIONAL   \n",
       "387083  NO PHASE           0       OTHER  INTERVENTIONAL   \n",
       "190858  NO PHASE           0       OTHER  INTERVENTIONAL   \n",
       "320731  NO PHASE           0       OTHER  INTERVENTIONAL   \n",
       "301789  NO PHASE           0       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                             Study Design  Start Date  \\\n",
       "240609  Allocation: NON_RANDOMIZED|Intervention Model:...     2020-07   \n",
       "387083  Allocation: RANDOMIZED|Intervention Model: PAR...     unknown   \n",
       "190858  Allocation: RANDOMIZED|Intervention Model: CRO...  2022-06-01   \n",
       "320731  Allocation: RANDOMIZED|Intervention Model: PAR...     2015-12   \n",
       "301789  Allocation: RANDOMIZED|Intervention Model: PAR...     2019-06   \n",
       "\n",
       "       Primary Completion Date Completion Date First Posted  \\\n",
       "240609                 2021-11         2021-11   2018-03-13   \n",
       "387083                 unknown         2010-12   2005-09-15   \n",
       "190858              2024-03-31      2024-11-30   2020-03-13   \n",
       "320731                 2015-12         2015-12   2015-11-05   \n",
       "301789                 2020-03         2020-06   2018-04-03   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "240609         2020-05-08  Froedtert Hospital and Medical College of Wisc...  \n",
       "387083         2022-12-19  Orthopaedic Center, Aarhus University Hospital...  \n",
       "190858         2023-09-18  Ragle Human Nutrition Research Center, Davis, ...  \n",
       "320731         2017-12-06                                            unknown  \n",
       "301789         2019-12-13                                            unknown  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'WITHDRAWN'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fb95a431-cfef-419c-a967-040c4b8064d1",
   "metadata": {},
   "source": [
    "Withdrawn are finished studies that have stopped prematurely before enrolling it's first participant. Since this status essentially has the same meaning as the terminated status, we will group this in the same category."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "8ae62cb7-15d6-477b-886d-bf7f86f3040d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Use np.where() to replace 'WITHDRAWN' with 'TERMINATED'\n",
    "df['Study Status'] = np.where(df['Study Status'] == 'WITHDRAWN', 'TERMINATED', df['Study Status'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "75b2967a-c43a-4bf9-afb5-8bdb9e2a748f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                263380\n",
       "RECRUITING                66150\n",
       "UNKNOWN                   64828\n",
       "TERMINATED                41730\n",
       "NOT_YET_RECRUITING        20055\n",
       "ACTIVE_NOT_RECRUITING     19702\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "14d17cfb-de89-4377-8a77-5aabe31ad216",
   "metadata": {},
   "source": [
    "`RECRUITING`, `NOT_YET_RECRUITING`, and `ACTIVE_NOT_RECRUITING` are all study statuses that are **on-going** and is not finished yet. So let's remove those rows as well since it's not within the scope of the problem."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "9b3a47a5-1754-4703-8ecc-eabfdede9a75",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = RECRUITING, NOT_YET_RECRUITING, and ACTIVE_NOT_RECRUITING\n",
    "df.drop(index=df[df['Study Status'].isin(['RECRUITING', 'NOT_YET_RECRUITING', 'ACTIVE_NOT_RECRUITING'])].index, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "bb500bd2-a998-4873-add7-a5fabd948d81",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED     263380\n",
       "UNKNOWN        64828\n",
       "TERMINATED     41730\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7dc4f32b-2580-43e5-b521-1628e65c4085",
   "metadata": {},
   "source": [
    "Finally, we should check the `UNKNOWN` status to see if we can group or remove them."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "ac85ee3a-47c0-40fb-bb09-738373a2b05e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>208715</th>\n",
       "      <td>A Randomized Comparison of Clinical Outcomes B...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>PCI of diffuse long coronary lesions still rem...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Coronary Artery Disease</td>\n",
       "      <td>device: pci with absorb everolimus-eluting bio...</td>\n",
       "      <td>Incidence of composite of major adverse cardio...</td>\n",
       "      <td>none</td>\n",
       "      <td>Yonsei University</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>950</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2016-06</td>\n",
       "      <td>2019-05</td>\n",
       "      <td>2019-05</td>\n",
       "      <td>2016-06-10</td>\n",
       "      <td>2018-05-18</td>\n",
       "      <td>Division of Cardiology, Department of Internal...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>446403</th>\n",
       "      <td>Efficacy Study of Vitamin D to Treat Contrast-...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The investigators planned to research the effe...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Contrast-induced Nephropathy</td>\n",
       "      <td>drug: vitamin d3 tablets|drug: placebo</td>\n",
       "      <td>the prevalence of contrast-induced nephropathy...</td>\n",
       "      <td>a change in serum creatinine level, The change...</td>\n",
       "      <td>Chinese PLA General Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>306</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>2017-07</td>\n",
       "      <td>2017-07</td>\n",
       "      <td>2015-07-02</td>\n",
       "      <td>2016-10-25</td>\n",
       "      <td>PLA General Hospital, Beijing, Beijing, 100853...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197503</th>\n",
       "      <td>A Study to Evaluate the Safety and Anti-tumor ...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>This clinical trial is a Single-Center, Open, ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>biological: snk01 (super natural killer cells ...</td>\n",
       "      <td>Maximum Tolerated Dose of the dose of SNK01 + ...</td>\n",
       "      <td>Progression-free survival, Progression-Free Su...</td>\n",
       "      <td>NKMAX Co., Ltd.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1|PHASE2</td>\n",
       "      <td>24</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2021-07-08</td>\n",
       "      <td>2023-05-26</td>\n",
       "      <td>2023-05-26</td>\n",
       "      <td>2021-05-04</td>\n",
       "      <td>2021-07-21</td>\n",
       "      <td>Asan Medical Center, Seoul, Songpa-gu, 05505, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>318707</th>\n",
       "      <td>Safety &amp; Efficacy FloGraft (Micronized Human A...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Safety \\&amp; Efficacy of FloGraft (Micronized Hum...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Osteoarthritis, Knee</td>\n",
       "      <td>drug: mhacmb|other: placebo</td>\n",
       "      <td>Visual Analogue Scale (VAS), Decreased Pain Le...</td>\n",
       "      <td>Western Ontario and McMaster Universities Arth...</td>\n",
       "      <td>Applied Biologics, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>320</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-11</td>\n",
       "      <td>2019-02</td>\n",
       "      <td>2019-03</td>\n",
       "      <td>2018-02-22</td>\n",
       "      <td>2018-09-28</td>\n",
       "      <td>Texas Orthopedic Hospital, Houston, Texas, 770...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89060</th>\n",
       "      <td>Effects of Heating Massaging Vibrating Vicinit...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The aim of this experiment is to test the phar...</td>\n",
       "      <td>NO</td>\n",
       "      <td>DIABETES</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Hadassah Medical Organization</td>\n",
       "      <td>none</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>100</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2008-11</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2011-03-03</td>\n",
       "      <td>2011-03-03</td>\n",
       "      <td>Hadassah Medical Organization,, Jerusalem, Israel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193520</th>\n",
       "      <td>Miniflare Versus Long Protocol in Poor Responders</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The study is performed to compare the outcomes...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Infertility</td>\n",
       "      <td>drug: triptorelin|drug: combined oral contrace...</td>\n",
       "      <td>Number of oocytes retrieved, 6 months</td>\n",
       "      <td>none</td>\n",
       "      <td>Woman's Health University Hospital, Egypt</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>200</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2016-02</td>\n",
       "      <td>2016-09</td>\n",
       "      <td>2016-09</td>\n",
       "      <td>2016-02-12</td>\n",
       "      <td>2016-04-04</td>\n",
       "      <td>Kasr el aini hospital, Cairo, 12211, Egypt</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57292</th>\n",
       "      <td>Questionnaire for the Evaluation of Anger, Hos...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The incidence of aggression and violent behavi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cerebral Lesion</td>\n",
       "      <td>other: questionnaire</td>\n",
       "      <td>Questionnaire evaluation by Rasch methodology,...</td>\n",
       "      <td>none</td>\n",
       "      <td>Eric Durand</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>50</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2019-04-09</td>\n",
       "      <td>2021-12</td>\n",
       "      <td>2021-12</td>\n",
       "      <td>2019-07-26</td>\n",
       "      <td>2019-07-26</td>\n",
       "      <td>Brugmann University Hospital, Brussels, 1020, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62789</th>\n",
       "      <td>Effects of Whole Body Vibration Training in Pa...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Interstitial lung disease (ILD) is a diverse g...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Interstitial Lung Disease|Scleroderma|Idiopath...</td>\n",
       "      <td>other: whole body vibration training</td>\n",
       "      <td>Pulmonary Function Test, The pulmonary functio...</td>\n",
       "      <td>Timed Up and Go Test (TUG), TUG is a reliable ...</td>\n",
       "      <td>Istanbul University</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>60</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>2020-09</td>\n",
       "      <td>2020-09</td>\n",
       "      <td>2018-06-18</td>\n",
       "      <td>2020-07-30</td>\n",
       "      <td>Nur Selin Of, Istanbul, Istanbul University/Ce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>437020</th>\n",
       "      <td>Combine GELOX With Concurrent Radiation Therap...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>To evaluate the efficacy and safety of first-l...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Lymphoma, Extranodal NK-T-Cell</td>\n",
       "      <td>drug: gelox|radiation: ifrt</td>\n",
       "      <td>complete remission rate, 1.The criteria for th...</td>\n",
       "      <td>progression free survival, progression free su...</td>\n",
       "      <td>Sun Yat-sen University</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>40</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2014-03</td>\n",
       "      <td>2016-12</td>\n",
       "      <td>2017-03</td>\n",
       "      <td>2014-03-06</td>\n",
       "      <td>2016-04-20</td>\n",
       "      <td>Sun Yat-sen University Cancer Center; State Ke...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276932</th>\n",
       "      <td>Does Bupivacaine in Laparoscopic Portals Reduc...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The use of bupivacaine , an anesthesic, in lap...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pain</td>\n",
       "      <td>drug: saline solution (laparoscopic tubal liga...</td>\n",
       "      <td>Pain, at 15, 30 and 120 minutes and 14 hours a...</td>\n",
       "      <td>Use of medication for pain, at 15, 30 and 120 ...</td>\n",
       "      <td>Hospital de Clinicas de Porto Alegre</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>46</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2008-08</td>\n",
       "      <td>2009-03</td>\n",
       "      <td>2009-08</td>\n",
       "      <td>2008-12-18</td>\n",
       "      <td>2009-08-28</td>\n",
       "      <td>Hospital de ClÃ­nicas de Porto Alegre, Porto Al...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "208715  A Randomized Comparison of Clinical Outcomes B...      UNKNOWN   \n",
       "446403  Efficacy Study of Vitamin D to Treat Contrast-...      UNKNOWN   \n",
       "197503  A Study to Evaluate the Safety and Anti-tumor ...      UNKNOWN   \n",
       "318707  Safety & Efficacy FloGraft (Micronized Human A...      UNKNOWN   \n",
       "89060   Effects of Heating Massaging Vibrating Vicinit...      UNKNOWN   \n",
       "193520  Miniflare Versus Long Protocol in Poor Responders      UNKNOWN   \n",
       "57292   Questionnaire for the Evaluation of Anger, Hos...      UNKNOWN   \n",
       "62789   Effects of Whole Body Vibration Training in Pa...      UNKNOWN   \n",
       "437020  Combine GELOX With Concurrent Radiation Therap...      UNKNOWN   \n",
       "276932  Does Bupivacaine in Laparoscopic Portals Reduc...      UNKNOWN   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "208715  PCI of diffuse long coronary lesions still rem...            NO   \n",
       "446403  The investigators planned to research the effe...            NO   \n",
       "197503  This clinical trial is a Single-Center, Open, ...            NO   \n",
       "318707  Safety \\& Efficacy of FloGraft (Micronized Hum...            NO   \n",
       "89060   The aim of this experiment is to test the phar...            NO   \n",
       "193520  The study is performed to compare the outcomes...            NO   \n",
       "57292   The incidence of aggression and violent behavi...            NO   \n",
       "62789   Interstitial lung disease (ILD) is a diverse g...            NO   \n",
       "437020  To evaluate the efficacy and safety of first-l...            NO   \n",
       "276932  The use of bupivacaine , an anesthesic, in lap...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "208715                            Coronary Artery Disease   \n",
       "446403                       Contrast-induced Nephropathy   \n",
       "197503                         Non-small Cell Lung Cancer   \n",
       "318707                               Osteoarthritis, Knee   \n",
       "89060                                            DIABETES   \n",
       "193520                                        Infertility   \n",
       "57292                                     Cerebral Lesion   \n",
       "62789   Interstitial Lung Disease|Scleroderma|Idiopath...   \n",
       "437020                     Lymphoma, Extranodal NK-T-Cell   \n",
       "276932                                               Pain   \n",
       "\n",
       "                                            Interventions  \\\n",
       "208715  device: pci with absorb everolimus-eluting bio...   \n",
       "446403             drug: vitamin d3 tablets|drug: placebo   \n",
       "197503  biological: snk01 (super natural killer cells ...   \n",
       "318707                        drug: mhacmb|other: placebo   \n",
       "89060                                             unknown   \n",
       "193520  drug: triptorelin|drug: combined oral contrace...   \n",
       "57292                                other: questionnaire   \n",
       "62789                other: whole body vibration training   \n",
       "437020                        drug: gelox|radiation: ifrt   \n",
       "276932  drug: saline solution (laparoscopic tubal liga...   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "208715  Incidence of composite of major adverse cardio...   \n",
       "446403  the prevalence of contrast-induced nephropathy...   \n",
       "197503  Maximum Tolerated Dose of the dose of SNK01 + ...   \n",
       "318707  Visual Analogue Scale (VAS), Decreased Pain Le...   \n",
       "89060                                             unknown   \n",
       "193520              Number of oocytes retrieved, 6 months   \n",
       "57292   Questionnaire evaluation by Rasch methodology,...   \n",
       "62789   Pulmonary Function Test, The pulmonary functio...   \n",
       "437020  complete remission rate, 1.The criteria for th...   \n",
       "276932  Pain, at 15, 30 and 120 minutes and 14 hours a...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "208715                                               none   \n",
       "446403  a change in serum creatinine level, The change...   \n",
       "197503  Progression-free survival, Progression-Free Su...   \n",
       "318707  Western Ontario and McMaster Universities Arth...   \n",
       "89060                                                none   \n",
       "193520                                               none   \n",
       "57292                                                none   \n",
       "62789   Timed Up and Go Test (TUG), TUG is a reliable ...   \n",
       "437020  progression free survival, progression free su...   \n",
       "276932  Use of medication for pain, at 15, 30 and 120 ...   \n",
       "\n",
       "                                          Sponsor Collaborators     Sex  \\\n",
       "208715                          Yonsei University          none     ALL   \n",
       "446403               Chinese PLA General Hospital          none     ALL   \n",
       "197503                            NKMAX Co., Ltd.          none     ALL   \n",
       "318707                     Applied Biologics, LLC          none     ALL   \n",
       "89060               Hadassah Medical Organization          none    MALE   \n",
       "193520  Woman's Health University Hospital, Egypt          none  FEMALE   \n",
       "57292                                 Eric Durand          none     ALL   \n",
       "62789                         Istanbul University          none     ALL   \n",
       "437020                     Sun Yat-sen University          none     ALL   \n",
       "276932       Hospital de Clinicas de Porto Alegre          none  FEMALE   \n",
       "\n",
       "                       Age         Phases  Enrollment Funder Type  \\\n",
       "208715  ADULT, OLDER_ADULT       NO PHASE         950       OTHER   \n",
       "446403  ADULT, OLDER_ADULT       NO PHASE         306       OTHER   \n",
       "197503  ADULT, OLDER_ADULT  PHASE1|PHASE2          24    INDUSTRY   \n",
       "318707  ADULT, OLDER_ADULT         PHASE2         320    INDUSTRY   \n",
       "89060   ADULT, OLDER_ADULT       NO PHASE         100       OTHER   \n",
       "193520               ADULT       NO PHASE         200       OTHER   \n",
       "57292   ADULT, OLDER_ADULT       NO PHASE          50       OTHER   \n",
       "62789   ADULT, OLDER_ADULT       NO PHASE          60       OTHER   \n",
       "437020  ADULT, OLDER_ADULT         PHASE2          40       OTHER   \n",
       "276932               ADULT       NO PHASE          46       OTHER   \n",
       "\n",
       "            Study Type                                       Study Design  \\\n",
       "208715  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "446403  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "197503  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "318707  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "89060    OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "193520  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "57292   INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "62789   INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "437020  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "276932  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "        Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "208715     2016-06                 2019-05         2019-05   2016-06-10   \n",
       "446403     2015-07                 2017-07         2017-07   2015-07-02   \n",
       "197503  2021-07-08              2023-05-26      2023-05-26   2021-05-04   \n",
       "318707     2018-11                 2019-02         2019-03   2018-02-22   \n",
       "89060      2008-11                 unknown         unknown   2011-03-03   \n",
       "193520     2016-02                 2016-09         2016-09   2016-02-12   \n",
       "57292   2019-04-09                 2021-12         2021-12   2019-07-26   \n",
       "62789      2017-01                 2020-09         2020-09   2018-06-18   \n",
       "437020     2014-03                 2016-12         2017-03   2014-03-06   \n",
       "276932     2008-08                 2009-03         2009-08   2008-12-18   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "208715         2018-05-18  Division of Cardiology, Department of Internal...  \n",
       "446403         2016-10-25  PLA General Hospital, Beijing, Beijing, 100853...  \n",
       "197503         2021-07-21  Asan Medical Center, Seoul, Songpa-gu, 05505, ...  \n",
       "318707         2018-09-28  Texas Orthopedic Hospital, Houston, Texas, 770...  \n",
       "89060          2011-03-03  Hadassah Medical Organization,, Jerusalem, Israel  \n",
       "193520         2016-04-04         Kasr el aini hospital, Cairo, 12211, Egypt  \n",
       "57292          2019-07-26  Brugmann University Hospital, Brussels, 1020, ...  \n",
       "62789          2020-07-30  Nur Selin Of, Istanbul, Istanbul University/Ce...  \n",
       "437020         2016-04-20  Sun Yat-sen University Cancer Center; State Ke...  \n",
       "276932         2009-08-28  Hospital de ClÃ­nicas de Porto Alegre, Porto Al...  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'UNKNOWN'].sample(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "28af6cde-eb56-4963-a9a4-191ffb51927b",
   "metadata": {},
   "source": [
    "Since we don't know the status of these studies and we cannot classify them based on other columns without a strong bias. We will just drop all the unknown study status for now."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "4514fb3e-5b31-4af8-8fa4-8ef7f123537f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = `UNKNOWN`\n",
    "df.drop(index = df[df['Study Status'] == 'UNKNOWN'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "5af965e9-cae0-41da-818c-f8729bc75e4b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED     263380\n",
       "TERMINATED     41730\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4702f060-2b7a-4063-9836-a116fda0f28b",
   "metadata": {},
   "source": [
    "Great! Now that we have removed all the statuses that aren't related to predicting clinical trial terminations, we can convert the study status into binary values.\n",
    "\n",
    "Next, we need to reset the index for our dataframe and convert the terminated status into 1 and the completed status into 0."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "8e30e658-b219-46b6-9d11-464f9ff8553f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# reset dataframe index\n",
    "df.reset_index(drop = True, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "23ad8998-b014-42c7-9c8e-24f399cb5a08",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert Study Status values into binary\n",
    "df['Study Status'] = np.where(df['Study Status'] == 'TERMINATED', 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "cafb437d-d981-4ae9-bcae-4fa1688739ad",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "0    0.86323\n",
       "1    0.13677\n",
       "Name: proportion, dtype: float64"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity + distribution of data check\n",
    "df['Study Status'].value_counts(normalize=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f09ec54a-0078-467a-b390-4abd20bd1947",
   "metadata": {},
   "source": [
    "**Important Notes:**\n",
    "Wow there is a massive data imbalance in our dataset where 86.3% are completed and 13.7% are terminated trials. If we did not have a predictive model and guessed whether trials are completed or terminated, 86.3% of the time you would get a completed result. Therefore to analyze our models, we definitely need to look at precision and recall metrics to find out how good the model really is.\n",
    "\n",
    "To improve our data imbalance, we could perform some upsampling/desampling of the data during modelling to see how that will affect our results."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "13177f4c-2e6e-4566-b79c-ebeba5c61e91",
   "metadata": {},
   "source": [
    "Next, let's look into the `Study Results` which can be turned into a binary column as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "29654ac0-bfa6-4456-92e9-620980517fff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Results\n",
       "NO     0.799413\n",
       "YES    0.200587\n",
       "Name: proportion, dtype: float64"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Results'].value_counts(normalize = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6087556c-1c16-439f-b6e7-d285e9fe62e1",
   "metadata": {},
   "source": [
    "Around 80% of the studies did not post results. I wonder if this would have any affect on clinical trial terminations..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "e1a51e1d-3dcd-48e3-aa68-f232d1617bad",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert Study Results into binary\n",
    "df['Study Results'] = np.where(df['Study Results'] == 'YES', 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "f5eb26b5-8676-4df3-abfe-6feae362fbf3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators     Sex  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...     ALL   \n",
       "1          Society for Family Planning Research Fund  FEMALE   \n",
       "2            National Institute on Drug Abuse (NIDA)     ALL   \n",
       "3                                               none     ALL   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...     ALL   \n",
       "\n",
       "                         Age    Phases  Enrollment Funder Type  \\\n",
       "0               CHILD, ADULT  NO PHASE         250       OTHER   \n",
       "1  CHILD, ADULT, OLDER_ADULT  NO PHASE         176       OTHER   \n",
       "2         ADULT, OLDER_ADULT  NO PHASE           0       OTHER   \n",
       "3                      ADULT  NO PHASE         103       OTHER   \n",
       "4         ADULT, OLDER_ADULT    PHASE2          44       OTHER   \n",
       "\n",
       "       Study Type                                       Study Design  \\\n",
       "0  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2018-08-20              2019-01-20      2019-02-28   2018-08-14   \n",
       "1     2013-08                 2014-12         2014-12   2013-05-15   \n",
       "2     2021-03                 2022-03         2022-03   2019-03-11   \n",
       "3     2014-09                 2016-04         2016-05   2016-10-26   \n",
       "4     2010-01                 2012-08         2012-08   2010-01-25   \n",
       "\n",
       "  Last Update Posted                                          Locations  \n",
       "0         2019-05-21           Sangath, New Delhi, Delhi, 110016, India  \n",
       "1         2015-08-17  Palestinian Ministry of Health Maternal Child ...  \n",
       "2         2021-03-10                                            unknown  \n",
       "3         2016-10-26  University of Oregon, Social and Affective Neu...  \n",
       "4         2016-03-08  MUSC, Charleston, South Carolina, 294258908, U...  "
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5e041de0-44ba-4f92-8238-e5fca7a769c7",
   "metadata": {},
   "source": [
    "Next we will look into the `Sex` column and see if we can turn them into dummy variables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "e27f8b0d-f630-445e-8119-5b6a354d4ddc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Sex\n",
       "ALL        260212\n",
       "FEMALE      29436\n",
       "MALE        15105\n",
       "unknown       357\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Sex'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "393572ea-7b00-4ada-bb2e-5ab0640cfa93",
   "metadata": {},
   "source": [
    "Interesting to note that there are 357 unknowns. \n",
    "- We should be able to group them with 'ALL', because the study would only choose to recruit male or female participants if that was the requirement for their clinical trial.\n",
    "- Then we can turn this column into dummy variables with pd.get_dummies()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "ec236be3-ec43-4d4e-8146-409040e63a03",
   "metadata": {},
   "outputs": [],
   "source": [
    "# replacing `unknown` with `ALL`\n",
    "df['Sex'] = np.where(df['Sex'] == 'unknown', 'ALL', df['Sex'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "4b078eb9-e533-494b-9c02-bb9e6c2d4161",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...   \n",
       "1          Society for Family Planning Research Fund   \n",
       "2            National Institute on Drug Abuse (NIDA)   \n",
       "3                                               none   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...   \n",
       "\n",
       "                         Age    Phases  Enrollment Funder Type  \\\n",
       "0               CHILD, ADULT  NO PHASE         250       OTHER   \n",
       "1  CHILD, ADULT, OLDER_ADULT  NO PHASE         176       OTHER   \n",
       "2         ADULT, OLDER_ADULT  NO PHASE           0       OTHER   \n",
       "3                      ADULT  NO PHASE         103       OTHER   \n",
       "4         ADULT, OLDER_ADULT    PHASE2          44       OTHER   \n",
       "\n",
       "       Study Type                                       Study Design  \\\n",
       "0  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2018-08-20              2019-01-20      2019-02-28   2018-08-14   \n",
       "1     2013-08                 2014-12         2014-12   2013-05-15   \n",
       "2     2021-03                 2022-03         2022-03   2019-03-11   \n",
       "3     2014-09                 2016-04         2016-05   2016-10-26   \n",
       "4     2010-01                 2012-08         2012-08   2010-01-25   \n",
       "\n",
       "  Last Update Posted                                          Locations  \\\n",
       "0         2019-05-21           Sangath, New Delhi, Delhi, 110016, India   \n",
       "1         2015-08-17  Palestinian Ministry of Health Maternal Child ...   \n",
       "2         2021-03-10                                            unknown   \n",
       "3         2016-10-26  University of Oregon, Social and Affective Neu...   \n",
       "4         2016-03-08  MUSC, Charleston, South Carolina, 294258908, U...   \n",
       "\n",
       "   Sex_ALL  Sex_FEMALE  Sex_MALE  \n",
       "0        1           0         0  \n",
       "1        0           1         0  \n",
       "2        1           0         0  \n",
       "3        1           0         0  \n",
       "4        1           0         0  "
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating dummy variables with prefix\n",
    "sex_dummy = pd.get_dummies(df['Sex'], prefix='Sex', dtype=int)\n",
    "\n",
    "# Concatenate dummies to df and drop Sex column\n",
    "df = pd.concat([df, sex_dummy], axis = 1)\n",
    "df.drop(columns = 'Sex', inplace = True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "06397d8d-f3c1-478f-88a1-39e46cbc9412",
   "metadata": {},
   "source": [
    "This looks very good. Now we will move onto the `Age` column and try to break it down further for modelling."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "9cd67b22-6c18-4134-ad7a-ef7a3d6a5915",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Age\n",
       "ADULT, OLDER_ADULT           194578\n",
       "ADULT                         45937\n",
       "CHILD, ADULT, OLDER_ADULT     28746\n",
       "CHILD                         19260\n",
       "CHILD, ADULT                  12144\n",
       "OLDER_ADULT                    4445\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Age'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f45cdcb5-f9de-483f-989b-c27dbe3e8cd2",
   "metadata": {},
   "source": [
    "We can notice that one study can have multiple age groups. The most popular age group are studies that have both `ADULT` and `OLDER_ADULT` participants.\n",
    "- We can use str.get_dummies() to separate the groups and turn them into dummy variables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "d216390a-fcf5-4317-9acb-46b73db5eb07",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators    Phases  Enrollment  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...  NO PHASE         250   \n",
       "1          Society for Family Planning Research Fund  NO PHASE         176   \n",
       "2            National Institute on Drug Abuse (NIDA)  NO PHASE           0   \n",
       "3                                               none  NO PHASE         103   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...    PHASE2          44   \n",
       "\n",
       "  Funder Type      Study Type  \\\n",
       "0       OTHER  INTERVENTIONAL   \n",
       "1       OTHER  INTERVENTIONAL   \n",
       "2       OTHER  INTERVENTIONAL   \n",
       "3       OTHER  INTERVENTIONAL   \n",
       "4       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...  2018-08-20   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...     2013-08   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...     2021-03   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...     2014-09   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...     2010-01   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Last Update Posted  \\\n",
       "0              2019-01-20      2019-02-28   2018-08-14         2019-05-21   \n",
       "1                 2014-12         2014-12   2013-05-15         2015-08-17   \n",
       "2                 2022-03         2022-03   2019-03-11         2021-03-10   \n",
       "3                 2016-04         2016-05   2016-10-26         2016-10-26   \n",
       "4                 2012-08         2012-08   2010-01-25         2016-03-08   \n",
       "\n",
       "                                           Locations  Sex_ALL  Sex_FEMALE  \\\n",
       "0           Sangath, New Delhi, Delhi, 110016, India        1           0   \n",
       "1  Palestinian Ministry of Health Maternal Child ...        0           1   \n",
       "2                                            unknown        1           0   \n",
       "3  University of Oregon, Social and Affective Neu...        1           0   \n",
       "4  MUSC, Charleston, South Carolina, 294258908, U...        1           0   \n",
       "\n",
       "   Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  \n",
       "0         0          1          1                0  \n",
       "1         0          1          1                1  \n",
       "2         0          1          0                1  \n",
       "3         0          1          0                0  \n",
       "4         0          1          0                1  "
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating dummy variables with prefix\n",
    "age_dummy = df['Age'].str.get_dummies(sep=', ').add_prefix('Age_')\n",
    "\n",
    "# Concatenate dummies to df and drop Age column\n",
    "df = pd.concat([df, age_dummy], axis = 1)\n",
    "df.drop(columns = 'Age', inplace = True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8589f182-f264-43bc-97c5-5ac83f4feaf4",
   "metadata": {},
   "source": [
    "Next we will look at the trial `Phases` and investigate if we can group common values and turn them into dummy variables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "1e20b50a-22ff-4f6a-af24-e347c7343033",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Phases\n",
       "NO PHASE         168986\n",
       "PHASE2            38291\n",
       "PHASE1            32613\n",
       "PHASE3            27504\n",
       "PHASE4            22433\n",
       "PHASE1|PHASE2      8522\n",
       "PHASE2|PHASE3      4183\n",
       "EARLY_PHASE1       2578\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Phases'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "48b9f92c-8030-4a21-b1f2-652557b7ab85",
   "metadata": {},
   "source": [
    "**Notes**\n",
    "- \"EARLY_PHASE1\" consists of exploratory trials involving very limited human exposure and zero diagnostic or therapeutic intent.\n",
    "- \"PHASE1|PHASE2\" or \"PHASE2|PHASE3\" are studies that are a combination of the 2 phases. We can definitely separate these with dummies.\n",
    "- \"PHASE1\" are initial studies that look at side effects, increased/decreased dosages, early effectiveness of drugs.\n",
    "- \"PHASE2\" studies aim to determine common short-term side effects, and effectiveness of drugs under a specific environment.\n",
    "- \"PHASE3\" are trials conducted after preliminary evidence of effectiveness, and gather additional information of the overall drug performance.\n",
    "- \"PHASE4\" are FDA-approved drugs that look into benefits/risks and optimal use cases.\n",
    "- \"NO PHASE\" are studies that do not have a phase such as behavioural interventions or studies of devices.\n",
    "\n",
    "We can also use str.get_dummies() to get this column ready for modelling."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "9039ae64-12db-40c3-b21b-06498a8fecbe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "      <th>Phases_EARLY_PHASE1</th>\n",
       "      <th>Phases_NO PHASE</th>\n",
       "      <th>Phases_PHASE1</th>\n",
       "      <th>Phases_PHASE2</th>\n",
       "      <th>Phases_PHASE3</th>\n",
       "      <th>Phases_PHASE4</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>44</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators  Enrollment Funder Type  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...         250       OTHER   \n",
       "1          Society for Family Planning Research Fund         176       OTHER   \n",
       "2            National Institute on Drug Abuse (NIDA)           0       OTHER   \n",
       "3                                               none         103       OTHER   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...          44       OTHER   \n",
       "\n",
       "       Study Type                                       Study Design  \\\n",
       "0  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2018-08-20              2019-01-20      2019-02-28   2018-08-14   \n",
       "1     2013-08                 2014-12         2014-12   2013-05-15   \n",
       "2     2021-03                 2022-03         2022-03   2019-03-11   \n",
       "3     2014-09                 2016-04         2016-05   2016-10-26   \n",
       "4     2010-01                 2012-08         2012-08   2010-01-25   \n",
       "\n",
       "  Last Update Posted                                          Locations  \\\n",
       "0         2019-05-21           Sangath, New Delhi, Delhi, 110016, India   \n",
       "1         2015-08-17  Palestinian Ministry of Health Maternal Child ...   \n",
       "2         2021-03-10                                            unknown   \n",
       "3         2016-10-26  University of Oregon, Social and Affective Neu...   \n",
       "4         2016-03-08  MUSC, Charleston, South Carolina, 294258908, U...   \n",
       "\n",
       "   Sex_ALL  Sex_FEMALE  Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  \\\n",
       "0        1           0         0          1          1                0   \n",
       "1        0           1         0          1          1                1   \n",
       "2        1           0         0          1          0                1   \n",
       "3        1           0         0          1          0                0   \n",
       "4        1           0         0          1          0                1   \n",
       "\n",
       "   Phases_EARLY_PHASE1  Phases_NO PHASE  Phases_PHASE1  Phases_PHASE2  \\\n",
       "0                    0                1              0              0   \n",
       "1                    0                1              0              0   \n",
       "2                    0                1              0              0   \n",
       "3                    0                1              0              0   \n",
       "4                    0                0              0              1   \n",
       "\n",
       "   Phases_PHASE3  Phases_PHASE4  \n",
       "0              0              0  \n",
       "1              0              0  \n",
       "2              0              0  \n",
       "3              0              0  \n",
       "4              0              0  "
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating dummy variables with prefix\n",
    "phases_dummy = df['Phases'].str.get_dummies().add_prefix('Phases_')\n",
    "\n",
    "# Concatenate dummies to df and drop Phases column\n",
    "df = pd.concat([df, phases_dummy], axis = 1)\n",
    "df.drop(columns = 'Phases', inplace = True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "692a3547-2a05-4db4-b055-477233de7708",
   "metadata": {},
   "source": [
    "In the first notebook we found that the `Enrollment` column was heavily right skewed. Let's visualize this again and see how we can perform feature engineering."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "ff3db281-9718-49c1-9402-cfae2f3dfdcf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count    3.051100e+05\n",
       "mean     3.941437e+03\n",
       "std      4.116496e+05\n",
       "min      0.000000e+00\n",
       "25%      2.400000e+01\n",
       "50%      6.000000e+01\n",
       "75%      1.570000e+02\n",
       "max      1.888141e+08\n",
       "Name: Enrollment, dtype: float64"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# .describe() looks at the summary statistics of the column\n",
    "df['Enrollment'].describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e8ca68cb-98fa-44e7-8654-7579c2651a61",
   "metadata": {},
   "source": [
    "The distribution is insanely right skewed. Enrollment in each study ranges from 0 to 188 million participants while the **mean** being 3941 participants and **median** being 60 participants."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "f5212155-b5e9-424c-a20b-4a07c74fad2b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# visualize the distribution\n",
    "plt.figure()\n",
    "\n",
    "plt.hist(df['Enrollment'], bins = 15)\n",
    "plt.yscale('log') # log the y axis to minimize the counts\n",
    "\n",
    "plt.title('Number of Participants Enrolled in Each Study'.title())\n",
    "plt.xlabel('Number of Participants Enrolled')\n",
    "plt.ylabel('Log scale of Study Counts')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "26cb41d8-c3b0-407e-b266-93a70ef7ce77",
   "metadata": {},
   "source": [
    "Even with a log scale, it is hard to view the average participant enrolled in each study.\n",
    "- To prepare this column for modelling, we will perform **adaptive binning** which will place the bins according to the distribution of the data.\n",
    "- We will split the data into deciles where there will be 10% of the data in each bin.\n",
    "\n",
    "source: (https://mylearningsinaiml.wordpress.com/ml-models/feature-engineering/feature-engineering-numeric-data/)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "0d7bef89-2a78-45ea-80af-582e2e2e433f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.0            0.0\n",
       "0.1            9.0\n",
       "0.2           20.0\n",
       "0.3           30.0\n",
       "0.4           42.0\n",
       "0.5           60.0\n",
       "0.6           80.0\n",
       "0.7          120.0\n",
       "0.8          210.0\n",
       "0.9          491.0\n",
       "1.0    188814085.0\n",
       "Name: Enrollment, dtype: float64"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Create list that stores deciles\n",
    "quantile_list = np.arange(0.0, 1.1, 0.1)\n",
    "\n",
    "# .quantile() splits the distribution equally\n",
    "quantiles = df['Enrollment'].quantile(quantile_list)\n",
    "quantiles"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "03f0ae56-ffe1-4ce5-bc2e-ccf3e75611d5",
   "metadata": {},
   "source": [
    "Interesting to note that at the 90th percentile, the number of participants are between 0 and 491, and then the enrollment number jumps enormously.\n",
    "\n",
    "We can use pd.qcut() to discretize the values into equal sized quantiles."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "82f53d51-8ae8-472e-819a-58be98d04989",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Enrollment\n",
       "(9.0, 20.0]             35123\n",
       "(42.0, 60.0]            34239\n",
       "(-0.001, 9.0]           30899\n",
       "(80.0, 120.0]           30546\n",
       "(491.0, 188814085.0]    30484\n",
       "(210.0, 491.0]          30466\n",
       "(120.0, 210.0]          30311\n",
       "(20.0, 30.0]            29075\n",
       "(30.0, 42.0]            27622\n",
       "(60.0, 80.0]            26345\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# impute enrollment values with the new bins\n",
    "df['Enrollment'] = pd.qcut(df['Enrollment'], q = quantile_list)\n",
    "# sanity check\n",
    "df['Enrollment'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3cbab67e-de5e-4dd7-ac04-6f2fcfe472d1",
   "metadata": {},
   "source": [
    "Nice, this looks pretty evenly distributed. Now to prepare for modelling, we can turn these categories into dummy variables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "6bd8a74b-e045-4181-b0b3-c63669a95d89",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "      <th>Phases_EARLY_PHASE1</th>\n",
       "      <th>Phases_NO PHASE</th>\n",
       "      <th>Phases_PHASE1</th>\n",
       "      <th>Phases_PHASE2</th>\n",
       "      <th>Phases_PHASE3</th>\n",
       "      <th>Phases_PHASE4</th>\n",
       "      <th>Enrollment__(-0.001, 9.0]</th>\n",
       "      <th>Enrollment__(9.0, 20.0]</th>\n",
       "      <th>Enrollment__(20.0, 30.0]</th>\n",
       "      <th>Enrollment__(30.0, 42.0]</th>\n",
       "      <th>Enrollment__(42.0, 60.0]</th>\n",
       "      <th>Enrollment__(60.0, 80.0]</th>\n",
       "      <th>Enrollment__(80.0, 120.0]</th>\n",
       "      <th>Enrollment__(120.0, 210.0]</th>\n",
       "      <th>Enrollment__(210.0, 491.0]</th>\n",
       "      <th>Enrollment__(491.0, 188814085.0]</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators Funder Type  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...       OTHER   \n",
       "1          Society for Family Planning Research Fund       OTHER   \n",
       "2            National Institute on Drug Abuse (NIDA)       OTHER   \n",
       "3                                               none       OTHER   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...       OTHER   \n",
       "\n",
       "       Study Type                                       Study Design  \\\n",
       "0  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2018-08-20              2019-01-20      2019-02-28   2018-08-14   \n",
       "1     2013-08                 2014-12         2014-12   2013-05-15   \n",
       "2     2021-03                 2022-03         2022-03   2019-03-11   \n",
       "3     2014-09                 2016-04         2016-05   2016-10-26   \n",
       "4     2010-01                 2012-08         2012-08   2010-01-25   \n",
       "\n",
       "  Last Update Posted                                          Locations  \\\n",
       "0         2019-05-21           Sangath, New Delhi, Delhi, 110016, India   \n",
       "1         2015-08-17  Palestinian Ministry of Health Maternal Child ...   \n",
       "2         2021-03-10                                            unknown   \n",
       "3         2016-10-26  University of Oregon, Social and Affective Neu...   \n",
       "4         2016-03-08  MUSC, Charleston, South Carolina, 294258908, U...   \n",
       "\n",
       "   Sex_ALL  Sex_FEMALE  Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  \\\n",
       "0        1           0         0          1          1                0   \n",
       "1        0           1         0          1          1                1   \n",
       "2        1           0         0          1          0                1   \n",
       "3        1           0         0          1          0                0   \n",
       "4        1           0         0          1          0                1   \n",
       "\n",
       "   Phases_EARLY_PHASE1  Phases_NO PHASE  Phases_PHASE1  Phases_PHASE2  \\\n",
       "0                    0                1              0              0   \n",
       "1                    0                1              0              0   \n",
       "2                    0                1              0              0   \n",
       "3                    0                1              0              0   \n",
       "4                    0                0              0              1   \n",
       "\n",
       "   Phases_PHASE3  Phases_PHASE4  Enrollment__(-0.001, 9.0]  \\\n",
       "0              0              0                          0   \n",
       "1              0              0                          0   \n",
       "2              0              0                          1   \n",
       "3              0              0                          0   \n",
       "4              0              0                          0   \n",
       "\n",
       "   Enrollment__(9.0, 20.0]  Enrollment__(20.0, 30.0]  \\\n",
       "0                        0                         0   \n",
       "1                        0                         0   \n",
       "2                        0                         0   \n",
       "3                        0                         0   \n",
       "4                        0                         0   \n",
       "\n",
       "   Enrollment__(30.0, 42.0]  Enrollment__(42.0, 60.0]  \\\n",
       "0                         0                         0   \n",
       "1                         0                         0   \n",
       "2                         0                         0   \n",
       "3                         0                         0   \n",
       "4                         0                         1   \n",
       "\n",
       "   Enrollment__(60.0, 80.0]  Enrollment__(80.0, 120.0]  \\\n",
       "0                         0                          0   \n",
       "1                         0                          0   \n",
       "2                         0                          0   \n",
       "3                         0                          1   \n",
       "4                         0                          0   \n",
       "\n",
       "   Enrollment__(120.0, 210.0]  Enrollment__(210.0, 491.0]  \\\n",
       "0                           0                           1   \n",
       "1                           1                           0   \n",
       "2                           0                           0   \n",
       "3                           0                           0   \n",
       "4                           0                           0   \n",
       "\n",
       "   Enrollment__(491.0, 188814085.0]  \n",
       "0                                 0  \n",
       "1                                 0  \n",
       "2                                 0  \n",
       "3                                 0  \n",
       "4                                 0  "
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Create dummy variable\n",
    "enrollment_dummy = pd.get_dummies(df['Enrollment'], prefix= 'Enrollment_', dtype=int)\n",
    "\n",
    "# Concatenate dummies to df and drop Enrollment column\n",
    "df = pd.concat([df, enrollment_dummy], axis = 1)\n",
    "df.drop(columns = 'Enrollment', inplace = True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9b9bdf5e-2c2f-4104-9c21-8925276a6239",
   "metadata": {},
   "source": [
    "Now we will look at the `Study Type` column and see what preprocessing we can perform."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "c648eedb-2a10-4a1e-93d0-3b7aa74087fd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Type\n",
       "INTERVENTIONAL    0.796709\n",
       "OBSERVATIONAL     0.203291\n",
       "Name: proportion, dtype: float64"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Type'].value_counts(normalize = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "07023c3c-cae6-425e-9f41-96a4625cb444",
   "metadata": {},
   "source": [
    "Most of the study types in this clinical trial dataset are \"INTERVENTIONAL\" (79.7%) which are treatments or actions taken to prevent or treat disease. The rest are \"OBSERVATIONAL\" studies (20.3%) which are therapeutic, diagnostic or other treatments that do not have a specific intervention method.\n",
    "\n",
    "Since there are only 2 categories in this column, we can just assign binary values.\n",
    "- Interventional = 1\n",
    "- Observational = 0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "b60a4072-8a96-4480-b2d5-48931440e894",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Type\n",
       "1    243084\n",
       "0     62026\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Type'] = np.where(df['Study Type'] == 'INTERVENTIONAL', 1, 0)\n",
    "\n",
    "# sanity check\n",
    "df['Study Type'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cfaa6008-745a-4518-98a9-24ac026543c6",
   "metadata": {},
   "source": [
    "The `Funder Type` column is next."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "eae96d49-a56d-4805-a940-d2af9db6f43b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Funder Type\n",
       "OTHER        195419\n",
       "INDUSTRY      87685\n",
       "NIH            9185\n",
       "OTHER_GOV      6113\n",
       "FED            3245\n",
       "NETWORK        3031\n",
       "INDIV           397\n",
       "UNKNOWN          32\n",
       "AMBIG             3\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Funder Type'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2e4b55d4-eb7a-4a8b-9477-3d900d5199d0",
   "metadata": {},
   "source": [
    "- There are 9 unique values in this column with \"OTHER\" being the largest count.\n",
    "- We should be able to group \"AMBIG\" and \"UNKNOWN\" funder types with \"OTHER\".\n",
    "- There seems to be 2 major categories: Industry and Government related funding."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "ab12c858-0afd-475f-9f77-05e13ccd49e2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Funder Type\n",
       "OTHER        195454\n",
       "INDUSTRY      87685\n",
       "NIH            9185\n",
       "OTHER_GOV      6113\n",
       "FED            3245\n",
       "NETWORK        3031\n",
       "INDIV           397\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# use .isin to slice out AMBIG and UNKNOWN values to change\n",
    "df['Funder Type'] = np.where(df['Funder Type'].isin(['AMBIG', 'UNKNOWN']), 'OTHER', df['Funder Type'])\n",
    "\n",
    "# sanity check\n",
    "df['Funder Type'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52fe040e-5c0d-4427-8273-9ab768b5bf81",
   "metadata": {},
   "source": [
    "So far so good. Now let's look into a few of these Funder Types to see if we can group them some more."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "f39d9bd8-ab69-46a2-a679-75e1b15998fd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "      <th>Phases_EARLY_PHASE1</th>\n",
       "      <th>Phases_NO PHASE</th>\n",
       "      <th>Phases_PHASE1</th>\n",
       "      <th>Phases_PHASE2</th>\n",
       "      <th>Phases_PHASE3</th>\n",
       "      <th>Phases_PHASE4</th>\n",
       "      <th>Enrollment__(-0.001, 9.0]</th>\n",
       "      <th>Enrollment__(9.0, 20.0]</th>\n",
       "      <th>Enrollment__(20.0, 30.0]</th>\n",
       "      <th>Enrollment__(30.0, 42.0]</th>\n",
       "      <th>Enrollment__(42.0, 60.0]</th>\n",
       "      <th>Enrollment__(60.0, 80.0]</th>\n",
       "      <th>Enrollment__(80.0, 120.0]</th>\n",
       "      <th>Enrollment__(120.0, 210.0]</th>\n",
       "      <th>Enrollment__(210.0, 491.0]</th>\n",
       "      <th>Enrollment__(491.0, 188814085.0]</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>121288</th>\n",
       "      <td>Determination of the Optimum Delivery Route fo...</td>\n",
       "      <td>0</td>\n",
       "      <td>Epiphora or excessive tearing is a significant...</td>\n",
       "      <td>0</td>\n",
       "      <td>Epiphora</td>\n",
       "      <td>drug: botulinum toxin type a|drug: botulinum t...</td>\n",
       "      <td>Comparison of 1-minute Schirmer's test with an...</td>\n",
       "      <td>Comparison of side effect between each treatme...</td>\n",
       "      <td>Merbs, Shannath, M.D., Ph.D.</td>\n",
       "      <td>none</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2011-02</td>\n",
       "      <td>2012-09</td>\n",
       "      <td>2012-09</td>\n",
       "      <td>2011-01-25</td>\n",
       "      <td>2012-09-12</td>\n",
       "      <td>Wilmer Eye Institute, Baltimore, Maryland, 212...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54106</th>\n",
       "      <td>A Simple Clinical Maneuver to Reduce Laparosco...</td>\n",
       "      <td>0</td>\n",
       "      <td>A pulmonary recruitment maneuver at the end of...</td>\n",
       "      <td>0</td>\n",
       "      <td>Shoulder Pain</td>\n",
       "      <td>procedure: recruitment manouver</td>\n",
       "      <td>Intensity of shoulder pain, 48 hours after dis...</td>\n",
       "      <td>Incidence of Nausea and Vomiting, 24hrs after ...</td>\n",
       "      <td>Phelps, Paul, M.D.</td>\n",
       "      <td>University of California, San Francisco</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2004-02</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2005-02</td>\n",
       "      <td>2007-12-18</td>\n",
       "      <td>2007-12-18</td>\n",
       "      <td>Inland Valley and Rancho Springs Medical Cente...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298577</th>\n",
       "      <td>Stem Cell Study for Patients With Heart Disease</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to determine if c...</td>\n",
       "      <td>0</td>\n",
       "      <td>Chest Pain|Myocardial Ischemia|Heart Disease|C...</td>\n",
       "      <td>genetic: cell therapy - autologous cd34 positi...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Losordo, Douglas, M.D.</td>\n",
       "      <td>none</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: |Ma...</td>\n",
       "      <td>2004-01</td>\n",
       "      <td>2006-03</td>\n",
       "      <td>2006-06</td>\n",
       "      <td>2004-04-28</td>\n",
       "      <td>2008-01-29</td>\n",
       "      <td>Scripps Clinic, La Jolla, California, 92037, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16014</th>\n",
       "      <td>Safety Study of Depakote Versus Lithium in Afr...</td>\n",
       "      <td>1</td>\n",
       "      <td>It is hypothesized that Depakote will be bette...</td>\n",
       "      <td>0</td>\n",
       "      <td>Bipolar Disorder</td>\n",
       "      <td>drug: depakote|drug: lithium</td>\n",
       "      <td>psychopathology: YMRS, MADRS|Tolerability: Uku...</td>\n",
       "      <td>HAMD, CGI-BP, HAM A,CORE, MADRS</td>\n",
       "      <td>Lawson, William B., M.D., PhD, DFAPA</td>\n",
       "      <td>Abbott</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2006-12</td>\n",
       "      <td>2006-12</td>\n",
       "      <td>2006-12</td>\n",
       "      <td>2010-02-24</td>\n",
       "      <td>2010-02-24</td>\n",
       "      <td>Howard University Hospital, Washington, Distri...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49325</th>\n",
       "      <td>Toronto and Oak Ridge Photobiomodulation Study...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to evaluate clini...</td>\n",
       "      <td>0</td>\n",
       "      <td>Nonexudative Age-related Macular Degeneration</td>\n",
       "      <td>device: photobiomodulation (gentlewaves, warp 10)</td>\n",
       "      <td>Change in ETDRS Visual Acuity, prior to interv...</td>\n",
       "      <td>change in contrast sensitivity, prior to inter...</td>\n",
       "      <td>Merry, Graham, M.D.</td>\n",
       "      <td>none</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2009-01</td>\n",
       "      <td>2011-08</td>\n",
       "      <td>2011-08</td>\n",
       "      <td>2009-07-16</td>\n",
       "      <td>2011-11-18</td>\n",
       "      <td>Dr Robert Dotson, Oak Ridge, Tennessee, 37830,...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  Study Status  \\\n",
       "121288  Determination of the Optimum Delivery Route fo...             0   \n",
       "54106   A Simple Clinical Maneuver to Reduce Laparosco...             0   \n",
       "298577    Stem Cell Study for Patients With Heart Disease             0   \n",
       "16014   Safety Study of Depakote Versus Lithium in Afr...             1   \n",
       "49325   Toronto and Oak Ridge Photobiomodulation Study...             0   \n",
       "\n",
       "                                            Brief Summary  Study Results  \\\n",
       "121288  Epiphora or excessive tearing is a significant...              0   \n",
       "54106   A pulmonary recruitment maneuver at the end of...              0   \n",
       "298577  The purpose of this study is to determine if c...              0   \n",
       "16014   It is hypothesized that Depakote will be bette...              0   \n",
       "49325   The purpose of this study is to evaluate clini...              0   \n",
       "\n",
       "                                               Conditions  \\\n",
       "121288                                           Epiphora   \n",
       "54106                                       Shoulder Pain   \n",
       "298577  Chest Pain|Myocardial Ischemia|Heart Disease|C...   \n",
       "16014                                    Bipolar Disorder   \n",
       "49325       Nonexudative Age-related Macular Degeneration   \n",
       "\n",
       "                                            Interventions  \\\n",
       "121288  drug: botulinum toxin type a|drug: botulinum t...   \n",
       "54106                     procedure: recruitment manouver   \n",
       "298577  genetic: cell therapy - autologous cd34 positi...   \n",
       "16014                        drug: depakote|drug: lithium   \n",
       "49325   device: photobiomodulation (gentlewaves, warp 10)   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "121288  Comparison of 1-minute Schirmer's test with an...   \n",
       "54106   Intensity of shoulder pain, 48 hours after dis...   \n",
       "298577                                            unknown   \n",
       "16014   psychopathology: YMRS, MADRS|Tolerability: Uku...   \n",
       "49325   Change in ETDRS Visual Acuity, prior to interv...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "121288  Comparison of side effect between each treatme...   \n",
       "54106   Incidence of Nausea and Vomiting, 24hrs after ...   \n",
       "298577                                               none   \n",
       "16014                     HAMD, CGI-BP, HAM A,CORE, MADRS   \n",
       "49325   change in contrast sensitivity, prior to inter...   \n",
       "\n",
       "                                     Sponsor  \\\n",
       "121288          Merbs, Shannath, M.D., Ph.D.   \n",
       "54106                     Phelps, Paul, M.D.   \n",
       "298577                Losordo, Douglas, M.D.   \n",
       "16014   Lawson, William B., M.D., PhD, DFAPA   \n",
       "49325                    Merry, Graham, M.D.   \n",
       "\n",
       "                                  Collaborators Funder Type  Study Type  \\\n",
       "121288                                     none       INDIV           1   \n",
       "54106   University of California, San Francisco       INDIV           1   \n",
       "298577                                     none       INDIV           1   \n",
       "16014                                    Abbott       INDIV           1   \n",
       "49325                                      none       INDIV           1   \n",
       "\n",
       "                                             Study Design Start Date  \\\n",
       "121288  Allocation: RANDOMIZED|Intervention Model: PAR...    2011-02   \n",
       "54106   Allocation: RANDOMIZED|Intervention Model: PAR...    2004-02   \n",
       "298577  Allocation: RANDOMIZED|Intervention Model: |Ma...    2004-01   \n",
       "16014   Allocation: RANDOMIZED|Intervention Model: PAR...    2006-12   \n",
       "49325   Allocation: NA|Intervention Model: SINGLE_GROU...    2009-01   \n",
       "\n",
       "       Primary Completion Date Completion Date First Posted  \\\n",
       "121288                 2012-09         2012-09   2011-01-25   \n",
       "54106                  unknown         2005-02   2007-12-18   \n",
       "298577                 2006-03         2006-06   2004-04-28   \n",
       "16014                  2006-12         2006-12   2010-02-24   \n",
       "49325                  2011-08         2011-08   2009-07-16   \n",
       "\n",
       "       Last Update Posted                                          Locations  \\\n",
       "121288         2012-09-12  Wilmer Eye Institute, Baltimore, Maryland, 212...   \n",
       "54106          2007-12-18  Inland Valley and Rancho Springs Medical Cente...   \n",
       "298577         2008-01-29  Scripps Clinic, La Jolla, California, 92037, U...   \n",
       "16014          2010-02-24  Howard University Hospital, Washington, Distri...   \n",
       "49325          2011-11-18  Dr Robert Dotson, Oak Ridge, Tennessee, 37830,...   \n",
       "\n",
       "        Sex_ALL  Sex_FEMALE  Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  \\\n",
       "121288        1           0         0          1          0                1   \n",
       "54106         0           1         0          1          1                1   \n",
       "298577        1           0         0          1          0                1   \n",
       "16014         1           0         0          1          0                0   \n",
       "49325         1           0         0          1          0                1   \n",
       "\n",
       "        Phases_EARLY_PHASE1  Phases_NO PHASE  Phases_PHASE1  Phases_PHASE2  \\\n",
       "121288                    0                0              0              1   \n",
       "54106                     0                1              0              0   \n",
       "298577                    0                0              1              0   \n",
       "16014                     0                0              0              0   \n",
       "49325                     0                0              0              1   \n",
       "\n",
       "        Phases_PHASE3  Phases_PHASE4  Enrollment__(-0.001, 9.0]  \\\n",
       "121288              0              0                          0   \n",
       "54106               0              0                          0   \n",
       "298577              0              0                          0   \n",
       "16014               0              1                          0   \n",
       "49325               0              0                          0   \n",
       "\n",
       "        Enrollment__(9.0, 20.0]  Enrollment__(20.0, 30.0]  \\\n",
       "121288                        0                         1   \n",
       "54106                         0                         0   \n",
       "298577                        0                         1   \n",
       "16014                         0                         0   \n",
       "49325                         1                         0   \n",
       "\n",
       "        Enrollment__(30.0, 42.0]  Enrollment__(42.0, 60.0]  \\\n",
       "121288                         0                         0   \n",
       "54106                          0                         0   \n",
       "298577                         0                         0   \n",
       "16014                          0                         1   \n",
       "49325                          0                         0   \n",
       "\n",
       "        Enrollment__(60.0, 80.0]  Enrollment__(80.0, 120.0]  \\\n",
       "121288                         0                          0   \n",
       "54106                          0                          1   \n",
       "298577                         0                          0   \n",
       "16014                          0                          0   \n",
       "49325                          0                          0   \n",
       "\n",
       "        Enrollment__(120.0, 210.0]  Enrollment__(210.0, 491.0]  \\\n",
       "121288                           0                           0   \n",
       "54106                            0                           0   \n",
       "298577                           0                           0   \n",
       "16014                            0                           0   \n",
       "49325                            0                           0   \n",
       "\n",
       "        Enrollment__(491.0, 188814085.0]  \n",
       "121288                                 0  \n",
       "54106                                  0  \n",
       "298577                                 0  \n",
       "16014                                  0  \n",
       "49325                                  0  "
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Studies funded by individuals\n",
    "df[df['Funder Type']=='INDIV'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d12a25f-8a8c-4b5c-81fb-a26df1afaa81",
   "metadata": {},
   "source": [
    "Since the sample size of studies funded by individuals are very low, it is not worth looking into them as a separate category. Therefore, we will group them with \"OTHER\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "6ddc55fc-4f47-45a7-978a-d0f1e6a36645",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Funder Type\n",
       "OTHER        195851\n",
       "INDUSTRY      87685\n",
       "NIH            9185\n",
       "OTHER_GOV      6113\n",
       "FED            3245\n",
       "NETWORK        3031\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Funder Type'] = np.where(df['Funder Type'] == 'INDIV', 'OTHER', df['Funder Type'])\n",
    "\n",
    "# sanity check\n",
    "df['Funder Type'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "795036f6-3828-410e-84b7-114abb416f7c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "      <th>Phases_EARLY_PHASE1</th>\n",
       "      <th>Phases_NO PHASE</th>\n",
       "      <th>Phases_PHASE1</th>\n",
       "      <th>Phases_PHASE2</th>\n",
       "      <th>Phases_PHASE3</th>\n",
       "      <th>Phases_PHASE4</th>\n",
       "      <th>Enrollment__(-0.001, 9.0]</th>\n",
       "      <th>Enrollment__(9.0, 20.0]</th>\n",
       "      <th>Enrollment__(20.0, 30.0]</th>\n",
       "      <th>Enrollment__(30.0, 42.0]</th>\n",
       "      <th>Enrollment__(42.0, 60.0]</th>\n",
       "      <th>Enrollment__(60.0, 80.0]</th>\n",
       "      <th>Enrollment__(80.0, 120.0]</th>\n",
       "      <th>Enrollment__(120.0, 210.0]</th>\n",
       "      <th>Enrollment__(210.0, 491.0]</th>\n",
       "      <th>Enrollment__(491.0, 188814085.0]</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>117291</th>\n",
       "      <td>Conditioning Regimen Before Infusion of Alloge...</td>\n",
       "      <td>0</td>\n",
       "      <td>Unrelated Donor Hematopoietic Stem Cell Transp...</td>\n",
       "      <td>0</td>\n",
       "      <td>HEMATOLOGIC MALIGNANCIES</td>\n",
       "      <td>unknown</td>\n",
       "      <td>treatment-related mortality and engraftment, a...</td>\n",
       "      <td>regimen-related toxicities, graft-versus-host-...</td>\n",
       "      <td>Cooperative Study Group A for Hematology</td>\n",
       "      <td>none</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>0</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2003-12</td>\n",
       "      <td>2008-03</td>\n",
       "      <td>2008-12</td>\n",
       "      <td>2008-10-10</td>\n",
       "      <td>2011-06-10</td>\n",
       "      <td>Asan Medical Center, Seoul, 138-736, Korea, Re...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227498</th>\n",
       "      <td>Imatinib in Patients With Desmoid Tumor and Ch...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to determine whet...</td>\n",
       "      <td>0</td>\n",
       "      <td>Advanced Desmoid Tumor|Advanced Chondrosarcoma</td>\n",
       "      <td>drug: imatinib mesylate</td>\n",
       "      <td>Tumor response will be evaluated by different ...</td>\n",
       "      <td>none</td>\n",
       "      <td>Italian Sarcoma Group</td>\n",
       "      <td>none</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2007-05</td>\n",
       "      <td>2018-12</td>\n",
       "      <td>2018-12</td>\n",
       "      <td>2009-06-26</td>\n",
       "      <td>2023-10-05</td>\n",
       "      <td>Centro di Riferimento Oncologico - Unit of Med...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>272874</th>\n",
       "      <td>Pulses of Vincristine and Dexamethasone in BFM...</td>\n",
       "      <td>0</td>\n",
       "      <td>Studies in the 1970s and 1980s suggested that ...</td>\n",
       "      <td>0</td>\n",
       "      <td>Acute Lymphoblastic Leukemia</td>\n",
       "      <td>drug: vincristine|drug: dexamethasone</td>\n",
       "      <td>disease free survival</td>\n",
       "      <td>survival</td>\n",
       "      <td>International BFM Study Group</td>\n",
       "      <td>Associazione Italiana Ematologia Oncologia Ped...</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>1995-04</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2004-01</td>\n",
       "      <td>2006-12-14</td>\n",
       "      <td>2006-12-14</td>\n",
       "      <td>Department of Pediatric Hematology-Oncology, I...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290586</th>\n",
       "      <td>Comparison of the Fixed Combinations of Brimon...</td>\n",
       "      <td>0</td>\n",
       "      <td>This study compares the efficacy and tolerabil...</td>\n",
       "      <td>0</td>\n",
       "      <td>Open-Angle Glaucoma|Ocular Hypertension</td>\n",
       "      <td>drug: brimonidine tartrate 0.2%/timolol maleat...</td>\n",
       "      <td>Change from baseline in mean IOP., 12 weeks</td>\n",
       "      <td>Patient tolerability/comfort measured by Liker...</td>\n",
       "      <td>Bp Consulting, Inc</td>\n",
       "      <td>Allergan</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2005-01</td>\n",
       "      <td>2006-04</td>\n",
       "      <td>2006-04</td>\n",
       "      <td>2009-01-14</td>\n",
       "      <td>2009-01-14</td>\n",
       "      <td>Barrie, Ontario, Canada</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137724</th>\n",
       "      <td>Neoadjuvant Afatinib Window Study in Squamous ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The general objectives are to evaluate the pre...</td>\n",
       "      <td>0</td>\n",
       "      <td>Carcinoma, Squamous Cell of Head and Neck</td>\n",
       "      <td>drug: afatinib|other: observation</td>\n",
       "      <td>Reduction of tumor Standardised Uptake Volume ...</td>\n",
       "      <td>Evaluation of tumour response to treatment by ...</td>\n",
       "      <td>European Organisation for Research and Treatme...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>NETWORK</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2012-07</td>\n",
       "      <td>2015-08</td>\n",
       "      <td>2015-08</td>\n",
       "      <td>2012-02-24</td>\n",
       "      <td>2018-07-09</td>\n",
       "      <td>Institut Jules Bordet, Brussels, 1000, Belgium...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  Study Status  \\\n",
       "117291  Conditioning Regimen Before Infusion of Alloge...             0   \n",
       "227498  Imatinib in Patients With Desmoid Tumor and Ch...             0   \n",
       "272874  Pulses of Vincristine and Dexamethasone in BFM...             0   \n",
       "290586  Comparison of the Fixed Combinations of Brimon...             0   \n",
       "137724  Neoadjuvant Afatinib Window Study in Squamous ...             0   \n",
       "\n",
       "                                            Brief Summary  Study Results  \\\n",
       "117291  Unrelated Donor Hematopoietic Stem Cell Transp...              0   \n",
       "227498  The purpose of this study is to determine whet...              0   \n",
       "272874  Studies in the 1970s and 1980s suggested that ...              0   \n",
       "290586  This study compares the efficacy and tolerabil...              0   \n",
       "137724  The general objectives are to evaluate the pre...              0   \n",
       "\n",
       "                                            Conditions  \\\n",
       "117291                        HEMATOLOGIC MALIGNANCIES   \n",
       "227498  Advanced Desmoid Tumor|Advanced Chondrosarcoma   \n",
       "272874                    Acute Lymphoblastic Leukemia   \n",
       "290586         Open-Angle Glaucoma|Ocular Hypertension   \n",
       "137724       Carcinoma, Squamous Cell of Head and Neck   \n",
       "\n",
       "                                            Interventions  \\\n",
       "117291                                            unknown   \n",
       "227498                            drug: imatinib mesylate   \n",
       "272874              drug: vincristine|drug: dexamethasone   \n",
       "290586  drug: brimonidine tartrate 0.2%/timolol maleat...   \n",
       "137724                  drug: afatinib|other: observation   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "117291  treatment-related mortality and engraftment, a...   \n",
       "227498  Tumor response will be evaluated by different ...   \n",
       "272874                              disease free survival   \n",
       "290586        Change from baseline in mean IOP., 12 weeks   \n",
       "137724  Reduction of tumor Standardised Uptake Volume ...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "117291  regimen-related toxicities, graft-versus-host-...   \n",
       "227498                                               none   \n",
       "272874                                           survival   \n",
       "290586  Patient tolerability/comfort measured by Liker...   \n",
       "137724  Evaluation of tumour response to treatment by ...   \n",
       "\n",
       "                                                  Sponsor  \\\n",
       "117291           Cooperative Study Group A for Hematology   \n",
       "227498                              Italian Sarcoma Group   \n",
       "272874                      International BFM Study Group   \n",
       "290586                                 Bp Consulting, Inc   \n",
       "137724  European Organisation for Research and Treatme...   \n",
       "\n",
       "                                            Collaborators Funder Type  \\\n",
       "117291                                               none     NETWORK   \n",
       "227498                                               none     NETWORK   \n",
       "272874  Associazione Italiana Ematologia Oncologia Ped...     NETWORK   \n",
       "290586                                           Allergan     NETWORK   \n",
       "137724                               Boehringer Ingelheim     NETWORK   \n",
       "\n",
       "        Study Type                                       Study Design  \\\n",
       "117291           0          Observational Model: |Time Perspective: p   \n",
       "227498           1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "272874           1  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "290586           1  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "137724           1  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "       Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "117291    2003-12                 2008-03         2008-12   2008-10-10   \n",
       "227498    2007-05                 2018-12         2018-12   2009-06-26   \n",
       "272874    1995-04                 unknown         2004-01   2006-12-14   \n",
       "290586    2005-01                 2006-04         2006-04   2009-01-14   \n",
       "137724    2012-07                 2015-08         2015-08   2012-02-24   \n",
       "\n",
       "       Last Update Posted                                          Locations  \\\n",
       "117291         2011-06-10  Asan Medical Center, Seoul, 138-736, Korea, Re...   \n",
       "227498         2023-10-05  Centro di Riferimento Oncologico - Unit of Med...   \n",
       "272874         2006-12-14  Department of Pediatric Hematology-Oncology, I...   \n",
       "290586         2009-01-14                            Barrie, Ontario, Canada   \n",
       "137724         2018-07-09  Institut Jules Bordet, Brussels, 1000, Belgium...   \n",
       "\n",
       "        Sex_ALL  Sex_FEMALE  Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  \\\n",
       "117291        1           0         0          1          1                0   \n",
       "227498        1           0         0          1          0                1   \n",
       "272874        1           0         0          0          1                0   \n",
       "290586        1           0         0          1          0                1   \n",
       "137724        1           0         0          1          0                1   \n",
       "\n",
       "        Phases_EARLY_PHASE1  Phases_NO PHASE  Phases_PHASE1  Phases_PHASE2  \\\n",
       "117291                    0                1              0              0   \n",
       "227498                    0                0              0              1   \n",
       "272874                    0                0              0              0   \n",
       "290586                    0                0              0              0   \n",
       "137724                    0                0              0              1   \n",
       "\n",
       "        Phases_PHASE3  Phases_PHASE4  Enrollment__(-0.001, 9.0]  \\\n",
       "117291              0              0                          0   \n",
       "227498              0              0                          0   \n",
       "272874              0              1                          0   \n",
       "290586              0              1                          0   \n",
       "137724              0              0                          0   \n",
       "\n",
       "        Enrollment__(9.0, 20.0]  Enrollment__(20.0, 30.0]  \\\n",
       "117291                        0                         0   \n",
       "227498                        0                         0   \n",
       "272874                        0                         0   \n",
       "290586                        0                         0   \n",
       "137724                        0                         1   \n",
       "\n",
       "        Enrollment__(30.0, 42.0]  Enrollment__(42.0, 60.0]  \\\n",
       "117291                         0                         1   \n",
       "227498                         1                         0   \n",
       "272874                         0                         0   \n",
       "290586                         0                         0   \n",
       "137724                         0                         0   \n",
       "\n",
       "        Enrollment__(60.0, 80.0]  Enrollment__(80.0, 120.0]  \\\n",
       "117291                         0                          0   \n",
       "227498                         0                          0   \n",
       "272874                         0                          0   \n",
       "290586                         0                          0   \n",
       "137724                         0                          0   \n",
       "\n",
       "        Enrollment__(120.0, 210.0]  Enrollment__(210.0, 491.0]  \\\n",
       "117291                           0                           0   \n",
       "227498                           0                           0   \n",
       "272874                           0                           0   \n",
       "290586                           1                           0   \n",
       "137724                           0                           0   \n",
       "\n",
       "        Enrollment__(491.0, 188814085.0]  \n",
       "117291                                 0  \n",
       "227498                                 0  \n",
       "272874                                 1  \n",
       "290586                                 0  \n",
       "137724                                 0  "
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Network is next\n",
    "df[df['Funder Type']=='NETWORK'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "885d2afb-09a4-46c8-81cd-caf81db77369",
   "metadata": {},
   "source": [
    "These studies seem to be studied by a network of different Industries. We will group these categories with \"INDUSTRY\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "e48e329b-4343-4d40-8b23-f24cf8567874",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Funder Type\n",
       "OTHER        195851\n",
       "INDUSTRY      90716\n",
       "NIH            9185\n",
       "OTHER_GOV      6113\n",
       "FED            3245\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Funder Type'] = np.where(df['Funder Type'] == 'NETWORK', 'INDUSTRY', df['Funder Type'])\n",
    "\n",
    "# sanity check\n",
    "df['Funder Type'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e5eadb2f-d42f-4b5b-b957-d4ea315a13f2",
   "metadata": {},
   "source": [
    "The categories 'NIH', 'OTHER_GOV', and 'FED' all are government related agencies. We can group them into one single category called \"GOVERNMENT\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "ea01c419-abce-4fe1-95fc-c942cd47b141",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Funder Type\n",
       "OTHER         195851\n",
       "INDUSTRY       90716\n",
       "GOVERNMENT     18543\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# use .isin to slice out NIH, OTHER_GOV and FED values to impute\n",
    "df['Funder Type'] = np.where(df['Funder Type'].isin(['NIH', 'OTHER_GOV', 'FED']), 'GOVERNMENT', df['Funder Type'])\n",
    "\n",
    "# sanity check\n",
    "df['Funder Type'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1fe6f9e7-0a05-4d37-a0c8-b650bd98d41d",
   "metadata": {},
   "source": [
    "This looks much more organized and better for our model. Before we turn these categories into dummy variables, let's visualize the distribution because they look very different in counts!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "e197e114-1446-4f2e-99f0-4b0035938fd8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.show()\n",
    "\n",
    "df['Funder Type'].value_counts(normalize = True).plot(kind='barh')\n",
    "plt.title('Distribution of Clinical Studies within Funding Type'.title())\n",
    "plt.xlabel('% of Studies')\n",
    "plt.ylabel('Funder Type')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ffd9d1a8-e442-4424-b94c-def75383fef0",
   "metadata": {},
   "source": [
    "Most of the studies are in the \"OTHER\" funding type which are funded by Universities, Individuals, Unknowns, etc. There seems to be much fewer Government funded studies in the dataset, so this would be interesting to note.\n",
    "\n",
    "Now we will expand the `Funder Type` column into dummy variables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "606224d6-e822-471d-b0a8-6e631a7e8767",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "      <th>Phases_EARLY_PHASE1</th>\n",
       "      <th>Phases_NO PHASE</th>\n",
       "      <th>Phases_PHASE1</th>\n",
       "      <th>Phases_PHASE2</th>\n",
       "      <th>Phases_PHASE3</th>\n",
       "      <th>Phases_PHASE4</th>\n",
       "      <th>Enrollment__(-0.001, 9.0]</th>\n",
       "      <th>Enrollment__(9.0, 20.0]</th>\n",
       "      <th>Enrollment__(20.0, 30.0]</th>\n",
       "      <th>Enrollment__(30.0, 42.0]</th>\n",
       "      <th>Enrollment__(42.0, 60.0]</th>\n",
       "      <th>Enrollment__(60.0, 80.0]</th>\n",
       "      <th>Enrollment__(80.0, 120.0]</th>\n",
       "      <th>Enrollment__(120.0, 210.0]</th>\n",
       "      <th>Enrollment__(210.0, 491.0]</th>\n",
       "      <th>Enrollment__(491.0, 188814085.0]</th>\n",
       "      <th>Funder_Type__GOVERNMENT</th>\n",
       "      <th>Funder_Type__INDUSTRY</th>\n",
       "      <th>Funder_Type__OTHER</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators  Study Type  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...           1   \n",
       "1          Society for Family Planning Research Fund           1   \n",
       "2            National Institute on Drug Abuse (NIDA)           1   \n",
       "3                                               none           1   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...           1   \n",
       "\n",
       "                                        Study Design  Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...  2018-08-20   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...     2013-08   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...     2021-03   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...     2014-09   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...     2010-01   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Last Update Posted  \\\n",
       "0              2019-01-20      2019-02-28   2018-08-14         2019-05-21   \n",
       "1                 2014-12         2014-12   2013-05-15         2015-08-17   \n",
       "2                 2022-03         2022-03   2019-03-11         2021-03-10   \n",
       "3                 2016-04         2016-05   2016-10-26         2016-10-26   \n",
       "4                 2012-08         2012-08   2010-01-25         2016-03-08   \n",
       "\n",
       "                                           Locations  Sex_ALL  Sex_FEMALE  \\\n",
       "0           Sangath, New Delhi, Delhi, 110016, India        1           0   \n",
       "1  Palestinian Ministry of Health Maternal Child ...        0           1   \n",
       "2                                            unknown        1           0   \n",
       "3  University of Oregon, Social and Affective Neu...        1           0   \n",
       "4  MUSC, Charleston, South Carolina, 294258908, U...        1           0   \n",
       "\n",
       "   Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  Phases_EARLY_PHASE1  \\\n",
       "0         0          1          1                0                    0   \n",
       "1         0          1          1                1                    0   \n",
       "2         0          1          0                1                    0   \n",
       "3         0          1          0                0                    0   \n",
       "4         0          1          0                1                    0   \n",
       "\n",
       "   Phases_NO PHASE  Phases_PHASE1  Phases_PHASE2  Phases_PHASE3  \\\n",
       "0                1              0              0              0   \n",
       "1                1              0              0              0   \n",
       "2                1              0              0              0   \n",
       "3                1              0              0              0   \n",
       "4                0              0              1              0   \n",
       "\n",
       "   Phases_PHASE4  Enrollment__(-0.001, 9.0]  Enrollment__(9.0, 20.0]  \\\n",
       "0              0                          0                        0   \n",
       "1              0                          0                        0   \n",
       "2              0                          1                        0   \n",
       "3              0                          0                        0   \n",
       "4              0                          0                        0   \n",
       "\n",
       "   Enrollment__(20.0, 30.0]  Enrollment__(30.0, 42.0]  \\\n",
       "0                         0                         0   \n",
       "1                         0                         0   \n",
       "2                         0                         0   \n",
       "3                         0                         0   \n",
       "4                         0                         0   \n",
       "\n",
       "   Enrollment__(42.0, 60.0]  Enrollment__(60.0, 80.0]  \\\n",
       "0                         0                         0   \n",
       "1                         0                         0   \n",
       "2                         0                         0   \n",
       "3                         0                         0   \n",
       "4                         1                         0   \n",
       "\n",
       "   Enrollment__(80.0, 120.0]  Enrollment__(120.0, 210.0]  \\\n",
       "0                          0                           0   \n",
       "1                          0                           1   \n",
       "2                          0                           0   \n",
       "3                          1                           0   \n",
       "4                          0                           0   \n",
       "\n",
       "   Enrollment__(210.0, 491.0]  Enrollment__(491.0, 188814085.0]  \\\n",
       "0                           1                                 0   \n",
       "1                           0                                 0   \n",
       "2                           0                                 0   \n",
       "3                           0                                 0   \n",
       "4                           0                                 0   \n",
       "\n",
       "   Funder_Type__GOVERNMENT  Funder_Type__INDUSTRY  Funder_Type__OTHER  \n",
       "0                        0                      0                   1  \n",
       "1                        0                      0                   1  \n",
       "2                        0                      0                   1  \n",
       "3                        0                      0                   1  \n",
       "4                        0                      0                   1  "
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "funder_dummy = pd.get_dummies(df['Funder Type'], prefix='Funder_Type_', dtype=int)\n",
    "\n",
    "# concat the dummy variables and drop `Funder Type` in the dataframe\n",
    "df = pd.concat([df, funder_dummy], axis=1)\n",
    "df.drop(columns='Funder Type', inplace=True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bac152b4-3f53-4f75-805a-0306ca554103",
   "metadata": {},
   "source": [
    "Next let's clean up the date columns and make sure the data type is 'datetime'.\n",
    "- We should remove the columns `First Posted` and `Last Update Posted`, because the posting dates do not provide much insight in predicting trial terminations.\n",
    "- In the previous notebook, we filled in the missing dates with the string 'unknown'. We should've imputed an empty string instead, so we can change the data type.\n",
    "- Then we should convert the columns `Start Date`, `Primary Completion Date`, and `Completion Date` into datetime."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "96903aae-e42e-44ae-928e-43e3f1429f40",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop posted dates\n",
    "df.drop(columns = ['First Posted', 'Last Update Posted'], inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "e909bece-405a-4fe2-8eb7-77376e378f5d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 305110 entries, 0 to 305109\n",
      "Data columns (total 3 columns):\n",
      " #   Column                   Non-Null Count   Dtype         \n",
      "---  ------                   --------------   -----         \n",
      " 0   Start Date               302231 non-null  datetime64[ns]\n",
      " 1   Primary Completion Date  289034 non-null  datetime64[ns]\n",
      " 2   Completion Date          295375 non-null  datetime64[ns]\n",
      "dtypes: datetime64[ns](3)\n",
      "memory usage: 7.0 MB\n"
     ]
    }
   ],
   "source": [
    "# Change the unknowns of each column in dates into empty strings\n",
    "dates = ['Start Date', 'Primary Completion Date', 'Completion Date']\n",
    "\n",
    "for i in dates:\n",
    "    df[i] = np.where(df[i] == 'unknown', '', df[i])\n",
    "    # Change the data type into datetime\n",
    "    df[i] = pd.to_datetime(df[i], format='mixed')\n",
    "    \n",
    "# sanity check\n",
    "df[dates].info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4f196ed2-e5eb-4521-8daf-7a5b47cd50ac",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f1121df7-ba5f-418a-8422-cd723907d2b9",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c0a16ce0-2a7d-4844-900e-f41f997cd45f",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f9f625c4-d3c6-407a-a5b5-ca74bc286eca",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "472dbf33-9810-41f5-81e4-ef26804363f0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b5a79c8b-484d-468a-9c6b-1f0fbf079ab7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "eb26a52c-0d96-49c5-bce0-62ebee45f4fc",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "20c9ad75-51c7-4eeb-8d33-16d6e203c1a9",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3e049104-5f67-4970-9cd3-733f18b7bd28",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Collaborators'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "33549cd7-dbca-43af-92cd-1dba736e109e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6457f1dd-6cb8-40a4-8b5a-1d0a854a8ef0",
   "metadata": {},
   "outputs": [],
   "source": [
    "test = df['Collaborators'].str.split('|', n=1).str[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b1fef2e3-c1ee-42cb-be5b-30bf3440c044",
   "metadata": {},
   "outputs": [],
   "source": [
    "test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6263b653-4d39-4e9f-a5e5-93e74e17f5a4",
   "metadata": {},
   "outputs": [],
   "source": [
    "test.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f8db864a-8c54-4286-a729-019e8ffbfb60",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9a03c1d9-b604-418a-8158-88985b11310f",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b987ba25-f65f-4585-b5b3-aa7aa3c847d6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bf6c9940-4b7e-41c3-af14-62ee47462bc4",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Locations'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2d320c3c-f544-4c76-9d1f-d0376bc9bee6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6f10a869-8f0e-465f-862a-d4cf68e115c6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "4345b0ac-bc13-45bb-b06d-96f48b36644e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "      <th>Phases_EARLY_PHASE1</th>\n",
       "      <th>Phases_NO PHASE</th>\n",
       "      <th>Phases_PHASE1</th>\n",
       "      <th>Phases_PHASE2</th>\n",
       "      <th>Phases_PHASE3</th>\n",
       "      <th>Phases_PHASE4</th>\n",
       "      <th>Enrollment__(-0.001, 9.0]</th>\n",
       "      <th>Enrollment__(9.0, 20.0]</th>\n",
       "      <th>Enrollment__(20.0, 30.0]</th>\n",
       "      <th>Enrollment__(30.0, 42.0]</th>\n",
       "      <th>Enrollment__(42.0, 60.0]</th>\n",
       "      <th>Enrollment__(60.0, 80.0]</th>\n",
       "      <th>Enrollment__(80.0, 120.0]</th>\n",
       "      <th>Enrollment__(120.0, 210.0]</th>\n",
       "      <th>Enrollment__(210.0, 491.0]</th>\n",
       "      <th>Enrollment__(491.0, 188814085.0]</th>\n",
       "      <th>Funder_Type__GOVERNMENT</th>\n",
       "      <th>Funder_Type__INDUSTRY</th>\n",
       "      <th>Funder_Type__OTHER</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08-01</td>\n",
       "      <td>2014-12-01</td>\n",
       "      <td>2014-12-01</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03-01</td>\n",
       "      <td>2022-03-01</td>\n",
       "      <td>2022-03-01</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09-01</td>\n",
       "      <td>2016-04-01</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>1</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01-01</td>\n",
       "      <td>2012-08-01</td>\n",
       "      <td>2012-08-01</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators  Study Type  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...           1   \n",
       "1          Society for Family Planning Research Fund           1   \n",
       "2            National Institute on Drug Abuse (NIDA)           1   \n",
       "3                                               none           1   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...           1   \n",
       "\n",
       "                                        Study Design Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR... 2018-08-20   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:... 2013-08-01   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR... 2021-03-01   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR... 2014-09-01   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR... 2010-01-01   \n",
       "\n",
       "  Primary Completion Date Completion Date  \\\n",
       "0              2019-01-20      2019-02-28   \n",
       "1              2014-12-01      2014-12-01   \n",
       "2              2022-03-01      2022-03-01   \n",
       "3              2016-04-01      2016-05-01   \n",
       "4              2012-08-01      2012-08-01   \n",
       "\n",
       "                                           Locations  Sex_ALL  Sex_FEMALE  \\\n",
       "0           Sangath, New Delhi, Delhi, 110016, India        1           0   \n",
       "1  Palestinian Ministry of Health Maternal Child ...        0           1   \n",
       "2                                            unknown        1           0   \n",
       "3  University of Oregon, Social and Affective Neu...        1           0   \n",
       "4  MUSC, Charleston, South Carolina, 294258908, U...        1           0   \n",
       "\n",
       "   Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  Phases_EARLY_PHASE1  \\\n",
       "0         0          1          1                0                    0   \n",
       "1         0          1          1                1                    0   \n",
       "2         0          1          0                1                    0   \n",
       "3         0          1          0                0                    0   \n",
       "4         0          1          0                1                    0   \n",
       "\n",
       "   Phases_NO PHASE  Phases_PHASE1  Phases_PHASE2  Phases_PHASE3  \\\n",
       "0                1              0              0              0   \n",
       "1                1              0              0              0   \n",
       "2                1              0              0              0   \n",
       "3                1              0              0              0   \n",
       "4                0              0              1              0   \n",
       "\n",
       "   Phases_PHASE4  Enrollment__(-0.001, 9.0]  Enrollment__(9.0, 20.0]  \\\n",
       "0              0                          0                        0   \n",
       "1              0                          0                        0   \n",
       "2              0                          1                        0   \n",
       "3              0                          0                        0   \n",
       "4              0                          0                        0   \n",
       "\n",
       "   Enrollment__(20.0, 30.0]  Enrollment__(30.0, 42.0]  \\\n",
       "0                         0                         0   \n",
       "1                         0                         0   \n",
       "2                         0                         0   \n",
       "3                         0                         0   \n",
       "4                         0                         0   \n",
       "\n",
       "   Enrollment__(42.0, 60.0]  Enrollment__(60.0, 80.0]  \\\n",
       "0                         0                         0   \n",
       "1                         0                         0   \n",
       "2                         0                         0   \n",
       "3                         0                         0   \n",
       "4                         1                         0   \n",
       "\n",
       "   Enrollment__(80.0, 120.0]  Enrollment__(120.0, 210.0]  \\\n",
       "0                          0                           0   \n",
       "1                          0                           1   \n",
       "2                          0                           0   \n",
       "3                          1                           0   \n",
       "4                          0                           0   \n",
       "\n",
       "   Enrollment__(210.0, 491.0]  Enrollment__(491.0, 188814085.0]  \\\n",
       "0                           1                                 0   \n",
       "1                           0                                 0   \n",
       "2                           0                                 0   \n",
       "3                           0                                 0   \n",
       "4                           0                                 0   \n",
       "\n",
       "   Funder_Type__GOVERNMENT  Funder_Type__INDUSTRY  Funder_Type__OTHER  \n",
       "0                        0                      0                   1  \n",
       "1                        0                      0                   1  \n",
       "2                        0                      0                   1  \n",
       "3                        0                      0                   1  \n",
       "4                        0                      0                   1  "
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dd0d0d16-2c25-4634-a446-f7eb3eb8b749",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "30b2e239-f89b-47cb-87b4-c16ecbd8fce6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 305110 entries, 0 to 305109\n",
      "Data columns (total 41 columns):\n",
      " #   Column                            Non-Null Count   Dtype         \n",
      "---  ------                            --------------   -----         \n",
      " 0   Study Title                       305110 non-null  object        \n",
      " 1   Study Status                      305110 non-null  int32         \n",
      " 2   Brief Summary                     305110 non-null  object        \n",
      " 3   Study Results                     305110 non-null  int32         \n",
      " 4   Conditions                        305110 non-null  object        \n",
      " 5   Interventions                     305110 non-null  object        \n",
      " 6   Primary Outcome Measures          305110 non-null  object        \n",
      " 7   Secondary Outcome Measures        305110 non-null  object        \n",
      " 8   Sponsor                           305110 non-null  object        \n",
      " 9   Collaborators                     305110 non-null  object        \n",
      " 10  Study Type                        305110 non-null  int32         \n",
      " 11  Study Design                      305110 non-null  object        \n",
      " 12  Start Date                        302231 non-null  datetime64[ns]\n",
      " 13  Primary Completion Date           289034 non-null  datetime64[ns]\n",
      " 14  Completion Date                   295375 non-null  datetime64[ns]\n",
      " 15  Locations                         305110 non-null  object        \n",
      " 16  Sex_ALL                           305110 non-null  int32         \n",
      " 17  Sex_FEMALE                        305110 non-null  int32         \n",
      " 18  Sex_MALE                          305110 non-null  int32         \n",
      " 19  Age_ADULT                         305110 non-null  int64         \n",
      " 20  Age_CHILD                         305110 non-null  int64         \n",
      " 21  Age_OLDER_ADULT                   305110 non-null  int64         \n",
      " 22  Phases_EARLY_PHASE1               305110 non-null  int64         \n",
      " 23  Phases_NO PHASE                   305110 non-null  int64         \n",
      " 24  Phases_PHASE1                     305110 non-null  int64         \n",
      " 25  Phases_PHASE2                     305110 non-null  int64         \n",
      " 26  Phases_PHASE3                     305110 non-null  int64         \n",
      " 27  Phases_PHASE4                     305110 non-null  int64         \n",
      " 28  Enrollment__(-0.001, 9.0]         305110 non-null  int32         \n",
      " 29  Enrollment__(9.0, 20.0]           305110 non-null  int32         \n",
      " 30  Enrollment__(20.0, 30.0]          305110 non-null  int32         \n",
      " 31  Enrollment__(30.0, 42.0]          305110 non-null  int32         \n",
      " 32  Enrollment__(42.0, 60.0]          305110 non-null  int32         \n",
      " 33  Enrollment__(60.0, 80.0]          305110 non-null  int32         \n",
      " 34  Enrollment__(80.0, 120.0]         305110 non-null  int32         \n",
      " 35  Enrollment__(120.0, 210.0]        305110 non-null  int32         \n",
      " 36  Enrollment__(210.0, 491.0]        305110 non-null  int32         \n",
      " 37  Enrollment__(491.0, 188814085.0]  305110 non-null  int32         \n",
      " 38  Funder_Type__GOVERNMENT           305110 non-null  int32         \n",
      " 39  Funder_Type__INDUSTRY             305110 non-null  int32         \n",
      " 40  Funder_Type__OTHER                305110 non-null  int32         \n",
      "dtypes: datetime64[ns](3), int32(19), int64(9), object(10)\n",
      "memory usage: 73.3+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "aa150123-7622-4447-9b80-040718f317d7",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Funder_Type__INDUSTRY'].sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0fc990d8-cfa6-430d-a9ad-a243b03a3ddd",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "834dae2b-e599-4a8b-bfcc-ddfa633a7797",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Clinical_Trials_env",
   "language": "python",
   "name": "clinical_trials_env"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
